https://www.medthority.com/guidelines/lymphomas/lymphomas-esmo-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2026-02-17T16:01:55+00:00weekly0.7https://www.medthority.com/guidelines/lymphomas/diagnosis-and-treatment-of-burkitt-lymphoma-in-adults-clinical-practice-guidelines-from-ern-eurobloodnet/2026-02-19T11:52:09+00:00weekly0.7https://www.medthority.com/guidelines/lymphomas/peripheral-t--and-natural-killer-cell-lymphomas-esmoeha-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2026-02-19T10:01:26+00:00weekly0.7https://www.medthority.com/guidelines/lymphomas/primary-central-nervous-system-lymphomas-ehaesmo-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2026-02-19T10:12:57+00:00weekly0.7https://www.medthority.com/guidelines/lymphomas/management-of-relapsed-or-refractory-large-b-cell-lymphoma-bsh/2026-02-19T10:24:33+00:00weekly0.7https://www.medthority.com/guidelines/lymphomas/primary-mediastinal-b-cell-lymphoma-pmbcl-the-lysa-pragmatic-guidelines/2026-02-19T10:42:46+00:00weekly0.7https://www.medthority.com/guidelines/lymphomas/large-b-cell-lymphoma-the-lysa-pragmatic-guidelines/2026-02-19T10:55:55+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/seom-gotel-clinical-guidelines-on-diffuse-large-b-cell-lymphoma-update-2025/2026-02-23T14:13:55+00:00weekly0.7https://www.medthority.com/guidelines/osteoarthritis/eular-recommendations-for-the-non-pharmacological-core-management-of-hip-and-knee-osteoarthritis-2023-update/2026-02-23T15:20:42+00:00weekly0.7https://www.medthority.com/guidelines/osteoarthritis/occupational-therapy-practice-guidelines-for-nonoperative-management-of-osteoarthritis-and-rheumatoid-arthritis/2026-02-23T15:40:57+00:00weekly0.7https://www.medthority.com/guidelines/nasal-polyposis/brazilian-guideline-for-the-use-of-immunobiologicals-in-crswnp-2024-update/2026-02-09T10:44:16+00:00weekly0.7https://www.medthority.com/guidelines/myasthenia-gravis/portuguese-consensus-guidelines-for-the-diagnosis-and-treatment-of-myasthenia-gravis/2026-02-05T15:25:24+00:00weekly0.7https://www.medthority.com/guidelines/myasthenia-gravis/abn-autoimmune-myasthenia-gravis-management-guidelines-2025-update/2026-02-05T15:43:17+00:00weekly0.7https://www.medthority.com/guidelines/myasthenia-gravis/national-guidelines-for-diagnosis-treatment-and-management-of-myasthenia-gravis-in-israel/2026-02-05T16:15:49+00:00weekly0.7https://www.medthority.com/guidelines/myasthenia-gravis/consensus-guidelines-on-the-diagnosis-and-management-of-myasthenia-gravis---saudi-neurology-society/2026-02-06T10:44:47+00:00weekly0.7https://www.medthority.com/guidelines/idiopathic-pulmonary-fibrosis-ipf/idiopathic-pulmonary-fibrosis-an-update-and-progressive-pulmonary-fibrosis-in-adults-an-official-atsersjrsalat-clinical-practice-guideline/2026-03-02T13:58:21+00:00weekly0.7https://www.medthority.com/guidelines/idiopathic-pulmonary-fibrosis-ipf/french-practical-guidelines-for-the-diagnosis-and-management-of-idiopathic-pulmonary-fibrosis-2021-update/2026-03-02T14:15:06+00:00weekly0.7https://www.medthority.com/guidelines/idiopathic-pulmonary-fibrosis-ipf/pharmacological-treatment-of-idiopathic-pulmonary-fibrosis-update-and-progressive-pulmonary-fibroses-s2k-guideline-of-the-german-respiratory-society/2026-03-02T15:09:39+00:00weekly0.7https://www.medthority.com/guidelines/other-diseases-of-bladder-and-urethra/eau-guidelines-on-management-of-non-neurogenic-female-lower-urinary-tract-symptoms/2026-03-02T16:09:17+00:00weekly0.7https://www.medthority.com/guidelines/other-diseases-of-bladder-and-urethra/eau-guidelines-on-urethral-strictures/2026-03-02T16:18:48+00:00weekly0.7https://www.medthority.com/guidelines/osteoarthritis/aaos-management-of-osteoarthritis-of-the-hip-evidence-based-clinical-practice-guideline/2026-02-26T11:53:59+00:00weekly0.7https://www.medthority.com/guidelines/osteoporosis/nogg-2024-clinical-guideline-for-the-prevention-and-treatment-of-osteoporosis/2026-02-24T15:17:20+00:00weekly0.7https://www.medthority.com/guidelines/osteoporosis/evidence-based-guideline-for-the-management-of-osteoporosis-in-men/2026-02-24T15:32:44+00:00weekly0.7https://www.medthority.com/guidelines/osteoporosis/clinical-practice-guideline-for-management-of-osteoporosis-and-fracture-prevention-in-canada-2023-update/2026-02-26T09:30:06+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/ovarian-cancer-staging-and-follow-up-updated-guidelines-from-the-european-society-of-urogenital-radiology-female-pelvic-imaging-working-group/2026-03-05T09:59:44+00:00weekly0.7https://www.medthority.com/guidelines/Pancreatic-cancer/pancreatic-cancer-esmo-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2026-03-05T11:09:28+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/newly-diagnosed-and-relapsed-epithelial-ovarian-cancer-esmo-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2026-03-03T14:21:16+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/esmo-cpg-express-update-on-the-management-of-epithelial-ovarian-cancer/2026-03-03T14:35:39+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/esgoesmoesp-consensus-conference-recommendations-on-ovarian-cancer-pathology-and-molecular-biology-and-early-advanced-and-recurrent-disease/2026-03-03T14:48:19+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/clinical-guidelines-for-ovarian-cancer-the-korean-society-of-gynecologic-oncology-guidelines/2026-03-03T15:49:52+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/clinical-practice-guidelines-for-ovarian-cancer-an-update-to-the-korean-society-of-gynecologic-oncology-guidelines/2026-03-03T16:09:21+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/seom-geico-clinical-guideline-on-epithelial-ovarian-cancer-2023/2026-03-03T16:22:04+00:00weekly0.7https://www.medthority.com/guidelines/Pancreatic-cancer/esmo-cpg-express-update-on-the-management-of-metastatic-pancreatic-cancer/2026-03-05T11:41:33+00:00weekly0.7https://www.medthority.com/guidelines/Pancreatic-cancer/pan-asian-adapted-esmo-clinical-practice-guidelines-for-the-diagnosis-treatment-and-follow-up-of-patients-with-pancreatic-cancer/2026-03-05T13:45:09+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/best-practice-guidance-for-dietitians-on-the-nutritional-management-of-parkinsons/2026-03-05T14:41:04+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/guidelines-for-parkinsons-disease-treatment-motor-symptoms-brazilian-academy-of-neurology/2026-03-06T08:40:38+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/guidelines-for-parkinsons-disease-management-part-ii-non-motor-symptoms-brazilian-academy-of-neurology/2026-03-06T09:09:02+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/advanced-and-metastatic-prostate-cancer-esmo-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2026-03-10T13:39:04+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/local-and-locoregional-prostate-cancer-esmo-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2026-03-10T13:52:11+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/french-recommendations-from-the-afu-cancer-committee-for-prostate-cancer-2025-summary-of-changes/2026-03-10T14:33:15+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/aga-living-cpg-on-the-pharmacologic-management-of-moderate-to-severe-crohns-disease/2026-03-09T11:25:28+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/the-initial-immunosuppressive-treatment-for-children-and-young-people-with-immune-mediated-glomerular-diseases/2026-03-09T14:27:46+00:00weekly0.7https://www.medthority.com/guidelines/pompe-disease/recommendations-for-the-diagnosis-treatment-and-follow-up-of-late-onset-pompe-disease/2026-03-09T15:33:48+00:00weekly0.7https://www.medthority.com/guidelines/pompe-disease/the-european-reference-network-for-metabolic-diseases-metabern-clinical-pathway-recommendations-for-pompe-disease-acid-maltase-deficiency-glycogen-storage-disease-type-ii/2026-03-09T15:53:32+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/prostate-cancer-version-3.2026-nccn-clinical-practice-guidelines-in-oncology2026-03-12T13:27:48+00:00weekly0.7https://www.medthority.com/guidelines/psoriasis/euroguiderm-guideline-for-the-systemic-treatment-of-psoriasis-vulgaris/2026-03-17T09:56:53+00:00weekly0.7https://www.medthority.com/guidelines/psoriasis/s3-guideline-for-the-treatment-of-psoriasis-vulgaris-adapted-from-euroguiderm---part-1-treatment-recommendations-and-monitoring/2026-03-17T10:14:35+00:00weekly0.7https://www.medthority.com/guidelines/psoriasis/s3-guideline-for-the-treatment-of-psoriasis-vulgaris-adapted-from-euroguiderm---part-2-specific-clinical-and-comorbid-situations/2026-03-17T10:36:00+00:00weekly0.7https://www.medthority.com/guidelines/psoriasis/french-guidelines-on-systemic-treatments-for-moderate-to-severe-psoriasis-in-adults-update-2025/2026-03-17T11:33:59+00:00weekly0.7https://www.medthority.com/guidelines/glaucoma/european-glaucoma-society--a-guide-on-surgical-innovation-for-glaucoma/2025-11-10T11:55:46+00:00weekly0.7https://www.medthority.com/guidelines/glaucoma/european-glaucoma-society---terminology-and-guidelines-for-glaucoma-6th-edition/2025-11-10T13:30:25+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/management-of-patients-with-early-stage-non-small-cell-lung-cancer-an-american-college-of-chest-physicians-clinical-practice-guideline/2025-11-10T15:19:19+00:00weekly0.7https://www.medthority.com/guidelines/macular-degeneration/japanese-clinical-guidelines-for-neovascular-age-related-macular-degeneration/2025-11-24T14:41:25+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/the-european-guideline-on-management-of-major-bleeding-and-coagulopathy-following-trauma-sixth-edition/2025-10-30T10:47:40+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/esmo-clinical-practice-guideline-interim-update-on-the-use-of-targeted-therapy-in-acute-lymphoblastic-leukaemia/2025-10-30T11:52:12+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/esmo-clinical-practice-guideline-interim-update-on-new-targeted-therapies-in-the-first-line-and-at-relapse-of-chronic-lymphocytic-leukaemia/2025-10-30T11:55:47+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/2025-bsh-guideline-for-the-treatment-of-chronic-lymphocytic-leukaemia/2025-10-31T09:37:00+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/diagnosis-prognostic-factors-and-assessment-of-all-in-adults-2024-eln-recommendations-from-a-european-expert-panel/2025-10-31T09:54:59+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/2025-eln-recommendations-for-the-management-of-chronic-myeloid-leukemia/2025-10-31T10:22:42+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/management-of-all-in-adults-2024-eln-recommendations-from-a-european-expert-panel/2025-10-31T10:30:50+00:00weekly0.7https://www.medthority.com/guidelines/amyloid-transthyretin-attr-amyloidosis/suspicion-and-referral-of-patients-with-transthyretin-amyloid-cardiomyopathy-recommendations-by-a-portuguese-multidisciplinary-expert-panel/2025-11-07T09:55:32+00:00weekly0.7https://www.medthority.com/guidelines/hypertension/hypertension-canada-guideline-for-the-diagnosis-and-treatment-of-hypertension-in-adults-in-primary-care/2025-10-28T14:42:02+00:00weekly0.7https://www.medthority.com/guidelines/hypertension/european-guidelines-for-hypertension-in-2024-a-comparison-of-key-recommendations-for-clinical-practice/2025-10-28T15:18:54+00:00weekly0.7https://www.medthority.com/guidelines/hypertension/investigation-and-management-of-resistant-hypertension-british-and-irish-hypertension-society-position-statement/2025-10-28T15:28:39+00:00weekly0.7https://www.medthority.com/guidelines/hypertension/investigation-and-management-of-young-onset-hypertension-british-and-irish-hypertension-society-position-statement/2025-10-28T15:34:50+00:00weekly0.7https://www.medthority.com/guidelines/hypertension/2025-ahaacc-multisociety-guideline-for-the-prevention-detection-evaluation-and-management-of-high-blood-pressure-in-adults/2025-10-28T14:19:50+00:00weekly0.7https://www.medthority.com/guidelines/melanomas-of-skin/systemic-therapy-for-melanoma-asco-guideline-update/2025-11-24T15:24:04+00:00weekly0.7https://www.medthority.com/guidelines/melanomas-of-skin/european-consensus-based-interdisciplinary-guideline-for-melanoma.-part-1-diagnostics---update-20242025-11-25T10:26:35+00:00weekly0.7https://www.medthority.com/guidelines/melanomas-of-skin/european-consensus-based-interdisciplinary-guideline-for-melanoma.-part-2-treatment---update-20242025-11-25T10:46:17+00:00weekly0.7https://www.medthority.com/guidelines/melanomas-of-skin/seom-gem-clinical-guidelines-for-cutaneous-melanoma-2023/2025-11-25T11:05:54+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/sexual-health-and-wellbeing-and-the-menopause-an-emas-clinical-guide/2026-01-06T13:39:07+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/ese-clinical-practice-guideline-for-evaluation-and-management-of-menopause-and-the-perimenopause/2026-01-05T16:20:28+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/ims-recommendations-and-key-messages-on-womens-midlife-health-and-menopause/2026-01-06T09:18:27+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/management-of-menopausal-symptoms-following-treatment-of-gynaecological-cancer-bgcsbms/2026-01-06T09:39:55+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/management-of-unscheduled-bleeding-on-hormone-replacement-therapy-bms/2026-01-06T10:52:08+00:00weekly0.7https://www.medthority.com/guidelines/endometriosis/endometriosis-and-menopausal-health-an-emas-clinical-guide/2026-01-06T14:06:23+00:00weekly0.7https://www.medthority.com/guidelines/mood-disorders/canmat-2023-update-on-clinical-guidelines-for-management-of-major-depressive-disorder-in-adults/2026-01-06T14:38:11+00:00weekly0.7https://www.medthority.com/guidelines/mood-disorders/clinical-practice-guideline-for-the-assessment-and-treatment-of-children-and-adolescents-with-major-and-persistent-depressive-disorders/2026-01-06T15:34:23+00:00weekly0.7https://www.medthority.com/guidelines/congestive-heart-failure/2023-hrsaphrslahrs-guideline-on-cardiac-physiologic-pacing-for-the-avoidance-and-mitigation-of-heart-failure/2025-09-25T08:45:05+00:00weekly0.7https://www.medthority.com/guidelines/cushings-syndrome/delphi-panel-consensus-on-recommendations-for-thromboprophylaxis-of-vte-in-endogenous-cushings-syndrome-a-position-statement/2025-09-25T11:58:39+00:00weekly0.7https://www.medthority.com/guidelines/cushings-syndrome/management-of-osilodrostat-therapy-in-patients-with-cushings-syndrome-a-modified-delphi-consensus-panel/2025-09-25T13:37:38+00:00weekly0.7https://www.medthority.com/guidelines/cystic-fibrosis/cystic-fibrosis-foundation-evidence-based-guideline-for-the-management-of-crmscfspid/2025-09-26T08:39:19+00:00weekly0.7https://www.medthority.com/guidelines/cystic-fibrosis/cystic-fibrosis-newborn-screening-a-systematic-review-driven-consensus-guideline-from-the-united-states-cystic-fibrosis-foundation/2025-09-26T08:59:18+00:00weekly0.7https://www.medthority.com/guidelines/cystic-fibrosis/models-of-palliative-care-delivery-for-individuals-with-cystic-fibrosis-cystic-fibrosis-foundation-evidence-informed-consensus-guidelines/2025-09-26T09:19:09+00:00weekly0.7https://www.medthority.com/guidelines/cystic-fibrosis/brazilian-guidelines-for-the-pharmacological-treatment-of-the-pulmonary-symptoms-of-cystic-fibrosis/2025-09-26T09:42:13+00:00weekly0.7https://www.medthority.com/guidelines/cystic-fibrosis/australasian-guideline-for-the-performance-of-sweat-chloride-testing-3rd-edition-to-support-cystic-fibrosis-screening-diagnosis-and-monitoring/2025-11-10T11:23:24+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/guidelines-on-the-use-of-prophylactic-factor-replacement-for-children-and-adults-with-haemophilia-a-and-b/2025-09-23T08:20:11+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/measurement-of-heparin-direct-oral-anti-coagulants-and-other-non-coumarin-anti-coagulants-and-their-effects-on-haemostasis-assays-a-british-society-for-haematology-guideline/2025-09-23T08:40:00+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/diagnosis-and-management-of-heparin-induced-thrombocytopenia-third-edition/2025-09-23T09:03:45+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/the-assessment-and-management-of-bleeding-risk-prior-to-invasive-procedures/2025-09-23T09:08:52+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/wfh-guidelines-for-the-management-of-hemophilia-3rd-edition/2025-09-23T09:38:58+00:00weekly0.7https://www.medthority.com/guidelines/sleep-apnea/ers-and-esrs-statement-on-the-treatment-of-central-sleep-apnoea-with-adaptive-servo-ventilation/2025-09-23T12:54:46+00:00weekly0.7https://www.medthority.com/guidelines/sleep-apnea/management-of-persistent-post-adenotonsillectomy-obstructive-sleep-apnea-in-children-an-official-american-thoracic-society-clinical-practice-guideline/2025-09-23T13:14:14+00:00weekly0.7https://www.medthority.com/guidelines/sleep-apnea/guidelines-for-the-assessment-and-management-of-residual-sleepiness-in-obstructive-apnea-hypopnea-syndrome-endorsed-by-the-french-sleep-research-and-medicine-society-sfrms-and-the-french-speaking-society-of-respiratory-diseases-splf/2025-09-23T13:49:50+00:00weekly0.7https://www.medthority.com/guidelines/sleep-apnea/treatment-of-obstructive-sleep-apnea-syndrome-osas-with-mandibular-advancement-devices---portuguese-guidelines/2025-09-23T14:11:59+00:00weekly0.7https://www.medthority.com/guidelines/sleep-apnea/referral-of-adults-with-obstructive-sleep-apnea-for-surgical-consultation-an-american-academy-of-sleep-medicine-clinical-practice-guideline/2025-09-23T14:23:50+00:00weekly0.7https://www.medthority.com/guidelines/congestive-heart-failure/acute-heart-failure---an-efim-guideline-critical-appraisal-and-adaptation-for-internists/2025-09-23T15:10:51+00:00weekly0.7https://www.medthority.com/guidelines/chronic-obstructive-pulmonary-disease-copd-and-bronchiectasis/gold-science-committee-recommendations-for-the-use-of-pre--and-post-bronchodilator-spirometry-for-the-diagnosis-of-copd/2025-09-22T08:57:37+00:00weekly0.7https://www.medthority.com/guidelines/cidp/brazilian-academy-of-neurology-recommendations-for-diagnosis-management-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-cidp/2025-11-10T10:51:54+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/isth-clinical-practice-guideline-for-treatment-of-congenital-hemophilia-a-and-b-based-on-the-grade-methodology/2025-09-22T12:34:46+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/ash-isth-nhf-wfh-2021-guidelines-on-the-diagnosis-of-von-willebrand-disease/2025-09-22T13:25:37+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/ash-isth-nhf-wfh-2021-guidelines-on-the-management-of-von-willebrand-disease/2025-09-22T13:52:54+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/guideline-for-laboratory-diagnosis-and-monitoring-of-von-willebrand-disease-a-joint-guideline-from-the-ukhcdo-and-the-bsh/2025-09-22T14:12:26+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/ukhcdo-gene-therapy-taskforce-guidance-for-implementation-of-haemophilia-gene-therapy-into-routine-clinical-practice-for-adults/2025-09-22T14:38:05+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/liver-related-aspects-of-valoctocogene-roxaparvovec-gene-therapy-for-hemophilia-a-expert-guidance-for-clinical-practice/2025-09-23T07:51:25+00:00weekly0.7https://www.medthority.com/guidelines/chronic-kidney-disease/kdigo-2024-clinical-practice-guideline-for-the-evaluation-and-management-of-chronic-kidney-disease/2025-09-19T08:48:31+00:00weekly0.7https://www.medthority.com/guidelines/chronic-obstructive-pulmonary-disease-copd-and-bronchiectasis/european-respiratory-society-clinical-practice-guideline-palliative-care-for-people-with-copd-or-interstitial-lung-disease/2025-09-19T10:29:04+00:00weekly0.7https://www.medthority.com/guidelines/chronic-cough/guidelines-for-the-management-of-chronic-cough-in-adults.-endorsed-by-the-splf-sforl-sfpl-snfge2025-11-10T10:45:27+00:00weekly0.7https://www.medthority.com/guidelines/chronic-kidney-disease/uk-kidney-association-clinical-practice-guideline-update-of-anaemia-of-chronic-kidney-disease/2025-09-19T08:36:36+00:00weekly0.7https://www.medthority.com/guidelines/Cervical-cancer/secondary-prevention-of-cervical-cancer-asco-resourcestratified-guideline-update/2025-11-10T10:42:26+00:00weekly0.7https://www.medthority.com/guidelines/Cervical-cancer/seom-geico-clinical-guidelines-on-cervical-cancer-2023/2025-09-16T09:07:08+00:00weekly0.7https://www.medthority.com/guidelines/Cervical-cancer/the-abs-consensus-guidance-for-hybrid-intracavitary-interstitial-brachytherapy-for-locally-advanced-cervical-cancer/2025-09-16T09:22:34+00:00weekly0.7https://www.medthority.com/guidelines/endometriosis/carcsar-practice-statement-on-pelvic-mri-for-endometriosis/2025-09-30T14:28:54+00:00weekly0.7https://www.medthority.com/guidelines/endometriosis/acr-appropriateness-criteria-endometriosis/2025-09-30T14:58:11+00:00weekly0.7https://www.medthority.com/guidelines/deficiency-and-other-anaemia/guidelines-for-the-diagnosis-and-management-of-adult-aplastic-anaemia-a-british-society-for-haematology-guideline/2025-09-29T13:49:16+00:00weekly0.7https://www.medthority.com/guidelines/disorders-of-lipid-metabolism/aace-clinical-practice-guideline-on-pharmacologic-management-of-adults-with-dyslipidemia/2025-09-29T15:10:43+00:00weekly0.7https://www.medthority.com/guidelines/disorders-of-lipid-metabolism/2025-focused-update-of-the-2019-esceas-guidelines-for-the-management-of-dyslipidaemias/2025-09-30T08:34:26+00:00weekly0.7https://www.medthority.com/guidelines/disorders-of-lipid-metabolism/2019-esceas-guidelines-for-the-management-of-dyslipidaemias-lipid-modification-to-reduce-cardiovascular-risk/2025-09-30T09:04:54+00:00weekly0.7https://www.medthority.com/guidelines/disorders-of-lipid-metabolism/clinical-practice-recommendations-on-lipoprotein-apheresis-for-children-with-homozygous-familial-hypercholesterolaemia-an-expert-consensus-statement-from-erknet-and-espn/2025-09-30T09:20:16+00:00weekly0.7https://www.medthority.com/guidelines/disorders-of-lipid-metabolism/2021-canadian-cardiovascular-society-guidelines-for-the-management-of-dyslipidemia-for-the-prevention-of-cardiovascular-disease-in-adults/2025-09-30T09:56:01+00:00weekly0.7https://www.medthority.com/guidelines/sickle-cell-anaemia/practical-guide-for-disease-modifying-medication-management-of-children-and-adolescents-with-sickle-cell-disease/2025-09-30T10:13:06+00:00weekly0.7https://www.medthority.com/guidelines/deficiency-and-other-anaemia/aga-clinical-practice-update-on-management-of-iron-deficiency-anemia-expert-review/2025-09-30T10:37:35+00:00weekly0.7https://www.medthority.com/guidelines/deficiency-and-other-anaemia/approach-to-anaemia-in-gastrointestinal-disease-a-position-paper-by-the-espghan-gastroenterology-committee/2025-09-30T13:28:58+00:00weekly0.7https://www.medthority.com/guidelines/deficiency-and-other-anaemia/screening-and-supplementation-for-iron-deficiency-and-iron-deficiency-anemia-during-pregnancy-uspstf-recommendation-statement/2025-09-30T13:48:49+00:00weekly0.7https://www.medthority.com/guidelines/endometriosis/eshre-guideline-endometriosis/2025-09-30T14:12:16+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/eosinophilic-esophagitis-in-children-and-adolescents-a-clinical-practice-guideline/2025-10-02T09:00:50+00:00weekly0.7https://www.medthority.com/guidelines/epilepsy-convulsions/eanm-practice-guidelines-for-an-appropriate-use-of-pet-and-spect-for-patients-with-epilepsy/2025-10-02T13:01:08+00:00weekly0.7https://www.medthority.com/guidelines/epilepsy-convulsions/genetic-testing-and-counseling-for-the-unexplained-epilepsies-an-evidence-based-practice-guideline-of-the-national-society-of-genetic-counselors/2025-10-02T13:11:01+00:00weekly0.7https://www.medthority.com/guidelines/epilepsy-convulsions/updated-classification-of-epileptic-seizures-position-paper-of-the-international-league-against-epilepsy/2025-10-02T13:30:11+00:00weekly0.7https://www.medthority.com/guidelines/epilepsy-convulsions/outpatient-management-of-prolonged-seizures-and-seizure-clusters-to-prevent-progression-to-a-higher-level-emergency-consensus-recommendations-of-an-expert-working-group/2025-10-02T14:00:33+00:00weekly0.7https://www.medthority.com/guidelines/epilepsy-convulsions/teratogenesis-perinatal-and-neurodevelopmental-outcomes-after-in-utero-exposure-to-antiseizure-medication---practice-guideline-from-the-aan-aes-and-smfm/2025-10-02T14:34:08+00:00weekly0.7https://www.medthority.com/guidelines/epilepsy-convulsions/antiseizure-medication-withdrawal-in-seizure-free-patients-practice-advisory-update-summary---report-of-the-aan-guideline-subcommittee/2025-10-03T08:16:13+00:00weekly0.7https://www.medthority.com/guidelines/epilepsy-convulsions/treatment-of-seizures-in-the-neonate-guidelines-and-consensus-based-recommendations-special-report-from-the-ilae-task-force-on-neonatal-seizures/2025-11-10T11:43:36+00:00weekly0.7https://www.medthority.com/guidelines/gastric-cancer/pan-asian-adapted-esmo-clinical-practice-guidelines-for-the-diagnosis-treatment-and-follow-up-of-patients-with-gastric-cancer/2025-10-13T13:36:59+00:00weekly0.7https://www.medthority.com/guidelines/gastric-cancer/seom-gemcad-ttd-clinical-guideline-for-the-diagnosis-and-treatment-of-gastric-cancer-2023/2025-10-13T13:54:57+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/management-of-individuals-with-diabetes-at-high-risk-for-hypoglycemia-an-endocrine-society-clinical-practice-guideline/2025-10-09T08:29:04+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/preexisting-diabetes-and-pregnancy-an-endocrine-society-and-european-society-of-endocrinology-joint-clinical-practice-guideline/2025-10-09T08:55:27+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients-with-diabetes/2025-10-09T10:16:01+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/newer-pharmacologic-treatments-in-adults-with-type-2-diabetes-a-clinical-guideline-from-the-american-college-of-physicians/2025-10-06T10:15:56+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/ispad-clinical-practice-consensus-guidelines-2024-type-2-diabetes-in-children-and-adolescents/2025-10-06T10:36:06+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/the-use-of-automated-insulin-delivery-around-physical-activity-and-exercise-in-type-1-diabetes-a-position-statement-of-the-easd-and-the-ispad/2025-10-06T15:16:21+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/evidence-based-european-recommendations-for-the-dietary-management-of-diabetes/2025-10-07T09:30:52+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/automated-insulin-delivery-benefits-challenges-and-recommendations---easd--ada/2025-10-07T09:53:41+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/hyperglycaemic-crises-in-adults-with-diabetes-a-consensus-report---ada--easd/2025-10-07T10:25:29+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/management-of-hyperglycemia-in-hospitalized-adult-patients-in-non-critical-care-settings-an-endocrine-society-clinical-practice-guideline/2025-10-07T15:17:51+00:00weekly0.7https://www.medthority.com/guidelines/glaucoma/position-statement-on-nicotinamide-use-for-glaucoma-neuroprotection---2025---american-glaucoma-society-and-american-academy-of-ophthalmology/2025-10-14T09:11:57+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/kdigo-2025-clinical-practice-guideline-for-the-management-of-immunoglobulin-a-nephropathy-igan-and-immunoglobulin-a-vasculitis-igav/2025-10-14T10:21:35+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/kdigo-2024-clinical-practice-guideline-for-the-management-of-antineutrophil-cytoplasmic-antibody-ancaassociated-vasculitis/2025-10-14T10:29:46+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/ipna-clinical-practice-recommendations-for-the-diagnosis-and-management-of-children-with-iga-nephropathy-and-iga-vasculitis-nephritis/2025-10-14T12:43:30+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/2024-american-college-of-rheumatology-acr-guideline-for-the-screening-treatment-and-management-of-lupus-nephritis/2025-10-14T12:55:58+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/the-2024-aplar-consensus-on-the-management-of-lupus-nephritis/2025-10-14T13:13:18+00:00weekly0.7https://www.medthority.com/guidelines/gout/2021-aplar-clinical-practice-guideline-for-treatment-of-gout/2025-10-14T14:29:35+00:00weekly0.7https://www.medthority.com/guidelines/gout/2020-american-college-of-rheumatology-guideline-for-the-management-of-gout/2025-10-14T14:38:22+00:00weekly0.7https://www.medthority.com/guidelines/growth-hormone-deficiency/safety-of-growth-hormone-replacement-in-survivors-of-cancer-and-intracranial-and-pituitary-tumours-a-consensus-statement/2025-10-14T15:11:18+00:00weekly0.7https://www.medthority.com/guidelines/headache/evidence-based-guidelines-for-the-pharmacological-treatment-of-migraine/2025-10-16T10:01:52+00:00weekly0.7https://www.medthority.com/guidelines/headache/calcitonin-gene-related-peptide-targeting-therapies-are-a-first-line-option-for-the-prevention-of-migraine-an-american-headache-society-position-statement-update/2025-10-16T10:50:09+00:00weekly0.7https://www.medthority.com/guidelines/diabetes/glycaemic-management-during-enteral-feeding-for-people-with-diabetes-in-hospital/2025-10-09T12:56:28+00:00weekly0.7https://www.medthority.com/guidelines/hepatitis/easl-clinical-practice-guidelines-on-the-management-of-hepatitis-b-virus-infection/2025-10-21T09:06:14+00:00weekly0.7https://www.medthority.com/guidelines/hepatitis/easl-clinical-practice-guidelines-on-the-management-of-autoimmune-hepatitis/2025-11-17T10:17:45+00:00weekly0.7https://www.medthority.com/guidelines/hepatitis/aga-clinical-practice-guideline-on-the-prevention-and-treatment-of-hepatitis-b-birus-reactivation-in-at-risk-individuals/2025-10-21T10:01:20+00:00weekly0.7https://www.medthority.com/guidelines/heart-valve-disorders/management-of-echocardiography-requests-for-the-detection-and-follow-up-of-heart-valve-disease-a-consensus-statement-from-the-british-heart-valve-society/2025-10-20T13:24:54+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/consensus-recommendations-for-the-use-of-novel-antiretrovirals-in-persons-with-hiv-who-are-heavily-treatment-experienced-andor-have-multidrug-resistant-hiv-1-endorsed-by-the-american-academy-of-hiv-medicine-american-college-of-clinical-pharmacy/2025-10-24T08:29:33+00:00weekly0.7https://www.medthority.com/guidelines/hidradenitis-suppurativa/european-s2k-guidelines-for-hidradenitis-suppurativaacne-inversa-part-2-treatment/2025-10-23T08:49:52+00:00weekly0.7https://www.medthority.com/guidelines/hidradenitis-suppurativa/quality-of-life-measurement-in-hidradenitis-suppurativa-position-statement-of-the-eadv/2025-10-23T09:38:57+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/bhiva-guidelines-on-the-management-of-hiv-in-pregnancy-and-the-postpartum-period-2025/2025-10-23T11:16:43+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/eacs-guidelines-version-13.02025-10-23T13:07:38+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/bhiva-guidelines-on-antiretroviral-treatment-for-adults-living-with-hiv-1-2022/2025-10-23T13:51:54+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/management-of-low-level-hiv-viremia-during-antiretroviral-therapy-delphi-consensus-statement-and-appraisal-of-the-evidence/2025-10-23T14:51:55+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/antiretroviral-postexposure-prophylaxis-after-sexual-injection-drug-use-or-other-nonoccupational-exposure-to-hiv---cdc-recommendations-united-states-2025/2025-10-23T15:08:58+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/advanced-imaging-for-earlier-diagnosis-and-morbidity-prevention-in-multiple-myeloma-a-bsh-and-uk-myeloma-society-good-practice-paper/2026-01-08T11:36:16+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/imsimwg-recommendations-on-the-definition-of-high-risk-multiple-myeloma/2026-01-08T13:40:20+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/imwg-immunotherapy-committee-recommendation-on-sequencing-immunotherapy-for-treatment-of-multiple-myeloma/2026-01-08T14:02:46+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/management-and-response-assessment-of-car-t-cell-therapy-in-clinical-practice-for-relapsed-and-refractory-multiple-myeloma-imwg/2026-01-08T14:36:53+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/optimal-use-of-t-cell-engaging-bispecific-antibodies-in-multiple-myeloma-imwg/2026-01-08T14:53:54+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/management-of-multiple-myeloma-related-renal-impairment-recommendations-from-the-imwg/2026-01-08T15:04:35+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/consensus-guidelines-and-recommendations-for-infection-prevention-in-multiple-myeloma-a-report-from-the-imwg/2026-01-08T15:25:56+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/consensus-recommendations-for-diagnosis-and-treatment-of-multiple-sclerosis-2023-revision-of-the-menactrims-guidelines/2026-01-09T10:29:24+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/advancing-multiple-sclerosis-management-in-older-adults-ectrims/2026-01-09T10:51:20+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/using-disease-modifying-treatments-in-multiple-sclerosis-association-of-british-neurologists-abn-2024-guidance/2026-01-09T11:05:01+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/management-of-relapsed-multiple-myeloma-a-bsh-and-uk-myeloma-society-guideline/2026-01-08T10:38:16+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/guidelines-on-the-diagnosis-investigation-and-initial-treatment-of-myeloma-a-bshuk-myeloma-forum-guideline/2026-01-08T10:57:43+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-colon/localised-colon-cancer-esmo-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up/2025-09-05T10:27:47+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/sinonasal-malignancy-esmoeuracan-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2025-09-12T08:15:17+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/salivary-gland-cancer-esmoeuracan-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2025-09-12T08:15:32+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/squamous-cell-carcinoma-of-the-oral-cavity-larynx-oropharynx-and-hypopharynx-ehns-esmo-estro-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up/2025-09-12T08:20:20+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/nasopharyngeal-carcinoma-esmo-euracan-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up/2025-09-12T08:20:33+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/esmoeuracan-clinical-practice-guideline-update-for-nasopharyngeal-carcinoma-adjuvant-therapy-and-first-line-treatment-of-recurrentmetastatic-disease/2025-10-30T11:54:27+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/prevention-and-management-of-osteoradionecrosis-in-patients-with-head-and-neck-cancer-treated-with-radiation-therapy-isoo-mascc-asco-guideline/2025-09-12T08:23:52+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/transoral-robotic-surgery-in-the-multidisciplinary-care-of-patients-with-oropharyngeal-squamous-cell-carcinoma-asco-guideline/2025-09-12T08:24:07+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-head-and-neck/immunotherapy-and-biomarker-testing-in-recurrent-and-metastatic-head-and-neck-cancers-asco-guideline/2025-09-12T08:25:17+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-colon/pan-asian-adapted-esmo-clinical-practice-guidelines-for-the-diagnosis-treatment-and-follow-up-of-patients-with-localised-colon-cancer/2025-11-10T10:32:55+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-kidney-and-renal-pelvis/stereotactic-body-radiotherapy-for-primary-renal-cell-carcinoma-a-systematic-review-and-practice-guideline-from-the-international-society-of-stereotactic-radiosurgery-isrs/2025-09-12T08:14:40+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-kidney-and-renal-pelvis/management-of-metastatic-clear-cell-renal-cell-carcinoma-asco-guideline/2025-09-12T08:14:49+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-kidney-and-renal-pelvis/management-of-metastatic-renal-clear-cell-cancer-asco-guideline-rapid-recommendation-update/2025-09-12T08:14:57+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-colon/adjuvant-therapy-for-stage-ii-colon-cancer-asco-guideline-update/2025-11-10T10:32:39+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/easl-clinical-practice-guidelines-on-the-management-of-hepatocellular-carcinoma/2025-09-12T08:13:38+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/easl-ilca-clinical-practice-guidelines-on-the-management-of-intrahepatic-cholangiocarcinoma/2025-09-12T08:13:57+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/esmo-clinical-practice-guideline-interim-update-on-the-management-of-biliary-tract-cancer/2025-10-30T11:52:44+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/stereotactic-body-radiation-therapy-for-liver-metastases-systematic-review-and-meta-analysis-with-international-stereotactic-radiosurgery-society-isrs-practice-guidelines/2025-09-12T08:12:28+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/systemic-therapy-for-advanced-hepatocellular-carcinoma-asco-guideline-update/2025-11-10T10:35:11+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/aga-clinical-practice-guideline-on-systemic-therapy-for-hepatocellular-carcinoma/2025-09-12T08:12:11+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/apasl-clinical-practice-guidelines-on-systemic-therapy-for-hepatocellular-carcinoma-2024/2025-09-12T08:11:59+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-oesophagus/esmo-clinical-practice-guideline-interim-update-on-the-treatment-of-locally-advanced-oesophageal-and-oesophagogastric-junction-adenocarcinoma-and-metastatic-squamous-cell-carcinoma/2025-10-30T11:53:37+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-oesophagus/immunotherapy-and-targeted-therapy-for-advanced-gastroesophageal-cancer-asco-guideline/2026-03-05T10:24:19+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-oesophagus/immunotherapy-in-patients-with-locally-advanced-esophageal-carcinoma-asco-treatment-of-locally-advanced-esophageal-carcinoma-guideline-rapid-recommendation-update/2025-09-12T08:11:10+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-oesophagus/european-clinical-practice-guidelines-for-the-definition-diagnosis-and-treatment-of-oligometastatic-esophagogastric-cancer-omec-4/2025-09-12T08:41:07+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-other-male-genital-organs/penile-cancer-esmoeuracan-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2025-09-12T09:26:45+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-other-male-genital-organs/testicular-seminoma-and-non-seminoma-esmo-euracan-clinical-practice-guideline-for-diagnosis-treatment-and-follow-up/2025-09-12T09:46:23+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-other-male-genital-organs/eau-guidelines-on-testicular-cancer/2025-09-12T10:24:18+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-rectum-and-anus/systemic-therapy-for-stage-i-iii-anal-squamous-cell-carcinoma-asco-guideline/2025-09-12T11:04:00+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-rectum-and-anus/management-of-locally-advanced-rectal-cancer-asco-guideline/2025-09-15T08:15:55+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-rectum-and-anus/radiation-therapy-for-rectal-cancer-an-astro-clinical-practice-guideline-focused-update/2025-09-15T08:46:10+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-rectum-and-anus/radiation-therapy-for-anal-squamous-cell-carcinoma-an-astro-clinical-practice-guideline/2025-09-15T08:54:01+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-uterus/esgo-estro-esp-guidelines-for-the-management-of-patients-with-endometrial-carcinoma-update-2025/2025-09-15T10:11:59+00:00weekly0.7https://www.medthority.com/guidelines/Cervical-cancer/management-and-care-of-patients-with-invasive-cervical-cancer-asco-resource-stratified-guideline-rapid-recommendation-update/2025-11-10T10:44:04+00:00weekly0.7https://www.medthority.com/guidelines/cataract/controversies-consensuses-and-guidelines-on-modern-cataract-surgery-by-the-academy-of-asia-pacific-professors-of-ophthalmology-aappo/2025-09-15T14:09:32+00:00weekly0.7https://www.medthority.com/guidelines/cataract/cataract-in-the-adult-eye-preferred-practice-pattern/2025-09-15T14:21:02+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/ii-consensus-of-the-brazilian-society-of-dermatology-for-the-treatment-of-alopecia-areata/2025-07-07T09:22:41+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/guidelines-for-the-management-of-patients-with-alopecia-areata-in-korea-part-i-topical-and-device-based-treatment/2025-07-07T10:28:20+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/guidelines-for-the-management-of-patients-with-alopecia-areata-in-korea-part-ii-systemic-treatment/2025-07-07T10:37:57+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/iadvl-sig-pediatric-dermatology-academy-recommendations-on-childhood-alopecia-areata/2025-07-07T12:48:26+00:00weekly0.7https://www.medthority.com/guidelines/alpha-1-antitrypsin-deficiency/recommendations-for-the-diagnosis-and-treatment-of-alpha-1-antitrypsin-deficiency/2025-07-07T13:44:53+00:00weekly0.7https://www.medthority.com/guidelines/alpha-1-antitrypsin-deficiency/alpha-1-antitrypsin-deficiency-targeted-testing-and-augmentation-therapy-a-canadian-thoracic-society-meta-analysis-and-clinical-practice-guideline/2025-07-07T14:40:41+00:00weekly0.7https://www.medthority.com/guidelines/arterial-embolism-or-thrombosis/2024-esc-guidelines-for-the-management-of-peripheral-arterial-and-aortic-diseases/2025-11-10T09:23:29+00:00weekly0.7https://www.medthority.com/guidelines/arterial-embolism-or-thrombosis/2022-accaha-guideline-for-the-diagnosis-and-management-of-aortic-disease-a-report-of-the-american-heart-associationamerican-college-of-cardiology-joint-committee-on-clinical-practice-guidelines/2025-11-10T09:15:01+00:00weekly0.7https://www.medthority.com/guidelines/arterial-embolism-or-thrombosis/2024-accahaaacvprapmaabcscaisvmsvnsvssirvess-guideline-for-the-management-of-lower-extremity-peripheral-artery-disease-a-report-of-the-american-college-of-cardiologyamerican-heart-association-joint-committee-on-clinical-practice-guidelines/2025-08-04T08:39:44+00:00weekly0.7https://www.medthority.com/guidelines/chronic-coronary-syndromes/2023-ahaaccaccpaspcnlapcna-guideline-for-the-management-of-patients-with-chronic-coronary-disease-a-report-of-the-american-heart-associationamerican-college-of-cardiology-joint-committee-on-clinical-practice-guidelines/2025-08-04T09:32:36+00:00weekly0.7https://www.medthority.com/guidelines/asthma/eaaci-biologicals-guidelines-recommendations-for-severe-asthma/2025-11-10T09:47:14+00:00weekly0.7https://www.medthority.com/guidelines/asthma/aarc-and-palisi-clinical-practice-guideline-pediatric-critical-asthma/2025-11-10T09:44:42+00:00weekly0.7https://www.medthority.com/guidelines/asthma/recommendations-for-asthma-monitoring-in-children-a-pearl-document-endorsed-by-apapari-eaaci-interasma-reg-and-wao/2025-11-10T09:44:27+00:00weekly0.7https://www.medthority.com/guidelines/asthma/european-respiratory-society-clinical-practice-guidelines-for-the-diagnosis-of-asthma-in-children-aged-516years/2025-11-10T09:43:54+00:00weekly0.7https://www.medthority.com/guidelines/asthma/european-respiratory-society-short-guidelines-for-the-use-of-as-needed-icsformoterol-in-mild-asthma/2025-08-04T13:14:59+00:00weekly0.7https://www.medthority.com/guidelines/asthma/european-respiratory-society-guidelines-for-the-diagnosis-of-asthma-in-adults/2025-08-04T13:32:46+00:00weekly0.7https://www.medthority.com/guidelines/asthma/management-of-severe-asthma-a-european-respiratory-societyamerican-thoracic-society-guideline/2025-08-04T14:07:51+00:00weekly0.7https://www.medthority.com/guidelines/asthma/use-of-fractional-exhaled-nitric-oxide-to-guide-the-treatment-of-asthma-an-official-american-thoracic-society-clinical-practice-guideline/2025-11-10T09:29:41+00:00weekly0.7https://www.medthority.com/guidelines/asthma/practical-guidelines-for-asthma-management-pgam-digest-edition/2025-11-10T09:28:11+00:00weekly0.7https://www.medthority.com/guidelines/asthma/an-international-consensus-on-the-use-of-asthma-biologics-in-pregnancy/2025-08-04T14:51:19+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/2024-ehrahrsaphrslahrs-expert-consensus-statement-on-catheter-and-surgical-ablation-of-atrial-fibrillation/2025-11-10T10:10:40+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/the-sts-2023-clinical-practice-guidelines-for-the-surgical-treatment-of-atrial-fibrillation/2025-08-05T10:55:18+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/bladder-sparing-therapy-for-bacillus-calmette-guerinunresponsive-nonmuscle-invasive-bladder-cancer-international-bladder-cancer-group-recommendations-for-optimal-sequencing-and-patient-selection/2025-08-07T08:43:24+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/french-afu-cancer-committee-guidelines-update-2024-2026-muscle-invasive-bladder-cancer-mibc/2025-08-07T09:29:25+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/french-afu-cancer-committee-guidelines-update-2024-2026-non-muscle-invasive-bladder-cancer-nmibc/2025-08-07T09:33:18+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/french-afu-cancer-committee-guidelines-update-20242026-upper-urinary-tract-urothelial-cancer-utuc/2025-08-07T10:10:44+00:00weekly0.7https://www.medthority.com/guidelines/chronic-coronary-syndromes/2024-esc-guidelines-for-the-management-of-chronic-coronary-syndromes/2025-09-16T09:30:38+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/2024-esc-guidelines-for-the-management-of-atrial-fibrillation/2025-08-05T09:18:24+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/2023-accahaaccphrs-guideline-for-the-diagnosis-and-management-of-atrial-fibrillation-a-report-of-the-american-college-of-cardiologyamerican-heart-association-joint-committee-on-clinical-practice-guidelines/2025-08-05T10:09:07+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/2023-kasnet-guidelines-on-atrial-fibrillation-surgery/2025-11-10T09:47:47+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/new-onset-atrial-fibrillation-in-critically-ill-adult-patients-an-ssai-clinical-practice-guideline2/2025-08-05T12:45:37+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/2024-chinese-expert-consensus-guidelines-on-the-diagnosis-and-treatment-of-atrial-fibrillation-in-the-elderly/2025-08-05T12:58:31+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/the-sts-clinical-practice-guideline-on-surgical-management-of-oligometastatic-nsclc/2025-08-05T13:11:26+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/esmo-clinical-practice-guideline-interim-update-on-first-line-therapy-in-advanced-urothelial-carcinoma/2025-10-30T11:53:08+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/applying-recommendations-for-diagnostic-disclosure-of-mild-cognitive-impairment-and-dementia-practical-guidance-for-clinicians/2025-07-29T13:46:20+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/alzheimers-association-clinical-practice-guideline-for-the-diagnostic-evaluation-testing-counseling-and-disclosure-of-suspected-alzheimers-disease-and-related-disorders-detecd-adrd-executive-summary-of-recommendations-for-primary-care/2025-07-29T14:49:12+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/the-alzheimers-association-clinical-practice-guideline-for-the-diagnostic-evaluation-testing-counseling-and-disclosure-of-suspected-alzheimers-disease-and-related-disorders-detecd-adrd-executive-summary-of-recommendations-for-specialty-care/2025-07-29T15:08:39+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/the-alzheimers-association-appropriate-use-recommendations-for-blood-biomarkers-in-alzheimers-disease/2025-07-29T09:00:22+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/the-alzheimers-association-international-guidelines-for-handling-of-cerebrospinal-fluid-for-routine-clinical-measurements-of-amyloid--and-tau/2025-07-29T10:06:45+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/alzheimer-disease-anti-amyloid-immunotherapies-imaging-recommendations-and-practice-considerations-for-monitoring-of-amyloid-related-imaging-abnormalities/2025-07-29T10:34:46+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/anti-amyloid-monoclonal-antibodies-for-the-treatment-of-alzheimer-disease-intersocietal-recommendations-for-their-appropriate-use-in-switzerland/2025-07-29T12:44:37+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/guidelines-for-the-use-and-interpretation-of-alzheimers-disease-biomarkers-in-clinical-practice-in-brazil-recommendations-from-the-scientific-department-of-cognitive-neurology-and-aging-of-the-brazilian-academy-of-neurology/2025-07-29T13:04:18+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/occupational-therapy-practice-guidelines-for-adults-living-with-alzheimers-disease-and-related-neurocognitive-disorders/2025-07-29T13:12:15+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/european-intersocietal-recommendations-for-the-biomarker-based-diagnosis-of-neurocognitive-disorders/2025-07-31T10:35:16+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/alzheimers-association-clinical-practice-guideline-on-the-use-of-blood-based-biomarkers-in-the-diagnostic-workup-of-suspected-alzheimers-disease-within-specialized-care-settings/2025-07-31T11:03:06+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/peanut-allergy-diagnosis-a-2020-practice-parameter-update-systematic-review-and-grade-analysis/2025-08-01T08:28:54+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/drug-allergy-a-2022-practice-parameter-update/2025-08-01T08:41:50+00:00weekly0.7https://www.medthority.com/guidelines/allergic-rhinitis/rhinitis-2020-a-practice-parameter-update/2025-08-01T08:42:34+00:00weekly0.7https://www.medthority.com/guidelines/nasal-polyposis/the-joint-task-force-on-practice-parameters-grade-guidelines-for-the-medical-management-of-chronic-rhinosinusitis-with-nasal-polyposis/2025-08-01T09:07:31+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/a-consensus-approach-to-the-primary-prevention-of-food-allergy-through-nutrition-guidance-from-the-aaai-acaai--and-the-csaci/2025-08-01T09:32:02+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/sentinel-lymph-node-biopsy-in-early-stage-breast-cancer-asco-guideline-update/2025-08-11T07:47:31+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/pan-asian-adapted-esmo-clinical-practice-guidelines-for-the-diagnosis-treatment-and-follow-up-of-patients-with-early-breast-cancer/2025-11-10T10:21:17+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/pan-asian-adapted-esmo-clinical-practice-guidelines-for-the-diagnosis-staging-and-treatment-of-patients-with-metastatic-breast-cancer/2025-11-10T10:21:48+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/screening-for-breast-cancer-us-preventive-services-task-force-recommendation-statement/2025-08-07T14:26:11+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/partial-breast-irradiation-for-patients-with-early-stage-invasive-breast-cancer-or-ductal-carcinoma-in-situ-an-astro-clinical-practice-guideline/2025-08-07T14:47:27+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-bone-and-connective-tissue/uk-guidelines-for-the-management-of-soft-tissue-sarcomas/2025-08-12T08:41:11+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-bone-and-connective-tissue/uk-guidelines-for-the-management-of-bone-sarcomas/2025-08-12T08:55:35+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-bone-and-connective-tissue/bone-cancer-version-2.2025-nccn-clinical-practice-guidelines-in-oncology2025-08-12T09:10:26+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-bone-and-connective-tissue/stereotactic-body-radiotherapy-for-non-spine-bone-metastases-a-meta-analysis-and-international-stereotactic-radiosurgery-society-isrs-clinical-practice-guidelines/2025-08-12T10:32:17+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/eanoesmo-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up-of-patients-with-brain-metastasis-from-solid-tumours/2025-08-12T13:18:38+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/neurological-and-vascular-complications-of-primary-and-secondary-brain-tumours-eano-esmo-clinical-practice-guidelines-for-prophylaxis-diagnosis-treatment-and-follow-up/2025-08-12T13:28:53+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/treatment-for-brain-metastases-asco-sno-astro-guideline/2025-08-12T14:02:55+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/joint-eanmeanoranosnmmi-practice-guidelineprocedure-standard-for-pet-imaging-of-brain-metastases-version-1.02025-08-12T14:17:11+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/estro-eano-guideline-on-target-delineation-and-radiotherapy-details-for-glioblastoma/2025-08-12T14:42:45+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/eano-guideline-on-rational-molecular-testing-of-gliomas-glioneuronal-and-neuronal-tumors-in-adults-for-targeted-therapy-selection/2025-08-12T14:56:57+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/6th-and-7th-international-consensus-guidelines-for-the-management-of-advanced-breast-cancer-abc-guidelines-6-and-7/2025-08-11T08:22:45+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/optimal-adjuvant-chemotherapy-and-targeted-therapy-for-early-breast-cancercyclin-dependent-kinase-4-and-6-inhibitors-asco-guideline-rapid-recommendation-update/2025-08-11T08:50:09+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/endocrine-and-targeted-therapy-for-hormone-receptorpositive-human-epidermal-growth-factor-receptor-2negative-metastatic-breast-cancercapivasertib-fulvestrant-asco-rapid-recommendation-update/2025-11-10T10:24:14+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/germline-testing-in-patients-with-breast-cancer-ascosso-guideline/2025-08-11T09:33:42+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/human-epidermal-growth-factor-receptor-2-testing-in-breast-cancer-asco--cap-guideline-update/2025-08-11T10:02:54+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/testing-for-esr1-mutations-to-guide-therapy-for-hormone-receptorpositive-human-epidermal-growth-factor-receptor-2negative-metastatic-breast-cancer-asco-guideline-rapid-recommendation-update/2025-08-11T10:23:07+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/chemotherapy-and-targeted-therapy-for-endocrine-pretreated-or-hormone-receptornegative-metastatic-breast-cancer-asco-guideline-rapid-recommendation-update/2025-08-11T10:50:44+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/chemotherapy-and-targeted-therapy-for-human-epidermal-growth-factor-receptor-2negative-metastatic-breast-cancer-that-is-either-endocrine-pretreated-or-hormone-receptornegative-asco-guideline-rapid-recommendation-update/2025-08-11T10:51:13+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/biomarkers-for-systemic-therapy-in-metastatic-breast-cancer-asco-guideline-update/2025-08-11T12:28:49+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/use-of-immune-checkpoint-inhibitor-pembrolizumab-in-the-treatment-of-high-risk-early-stage-triple-negative-breast-cancer-asco-guideline-rapid-recommendation-update/2025-08-11T13:07:01+00:00weekly0.7https://www.medthority.com/guidelines/calculus-of-urinary-tract/international-alliance-of-urolithiasis-iau-guidelines-on-the-management-of-pediatric-urolithiasis/2025-08-11T14:15:17+00:00weekly0.7https://www.medthority.com/guidelines/calculus-of-urinary-tract/international-alliance-of-urolithiasis-iau-consensus-on-miniaturized-percutaneous-nephrolithotomy/2025-08-11T14:22:44+00:00weekly0.7https://www.medthority.com/guidelines/calculus-of-urinary-tract/international-alliance-of-urolithiasis-guideline-on-shockwave-lithotripsy/2025-08-11T14:45:12+00:00weekly0.7https://www.medthority.com/guidelines/calculus-of-urinary-tract/international-alliance-of-urolithiasis-guideline-on-retrograde-intrarenal-surgery/2025-08-11T14:44:58+00:00weekly0.7https://www.medthority.com/guidelines/calculus-of-urinary-tract/international-alliance-of-urolithiasis-iau-guideline-on-staghorn-calculi-management/2025-08-11T14:50:16+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/systemic-therapy-in-patients-with-metastatic-castration-resistant-prostate-cancer-asco-guideline-update/2025-05-19T15:05:46+00:00weekly0.7https://www.medthority.com/guidelines/polycystic-kidney-disease/kdigo-2025-clinical-practice-guideline-for-the-evaluation-management-and-treatment-of-autosomal-dominant-polycystic-kidney-disease-adpkd/2025-05-22T15:16:40+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/2022-eta-consensus-statement-what-are-the-indications-for-post-surgical-radioiodine-therapy-in-differentiated-thyroid-cancer/2025-05-20T13:16:37+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/the-2024-revised-clinical-guidelines-on-the-management-of-thyroid-tumors-by-the-japan-association-of-endocrine-surgery/2025-05-26T09:30:55+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/radiofrequency-ablation-for-recurrent-thyroid-cancers-2025-korean-society-of-thyroid-radiology-guideline/2025-05-26T09:45:31+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/seom-getne-ttcc-clinical-guideline-thyroid-cancer-2023/2025-05-26T10:02:15+00:00weekly0.7https://www.medthority.com/guidelines/adhd/remote-assessment-of-adhd-in-children-and-adolescents-recommendations-from-the-european-adhd-guidelines-group-following-the-clinical-experience-during-the-covid-19-pandemic/2025-05-27T08:25:56+00:00weekly0.7https://www.medthority.com/guidelines/adhd/practical-clinical-guidelines-and-pharmacological-treatment-for-attention-deficit-hyperactivity-disorder-in-asia/2025-05-27T08:56:38+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/eso-and-esmint-guideline-on-acute-management-of-basilar-artery-occlusion/2025-05-27T09:20:40+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/eso-guideline-on-visual-impairment-in-stroke/2025-05-27T11:09:31+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/eso-and-eans-guideline-on-stroke-due-to-spontaneous-intracerebral-haemorrhage/2025-05-27T10:59:06+00:00weekly0.7https://www.medthority.com/guidelines/acute-coronary-syndrome/2025-accahaacepnaemspscai-guideline-for-the-management-of-patients-with-acute-coronary-syndromes-a-report-of-the-american-college-of-cardiologyamerican-heart-association-joint-committee-on-clinical-practice-guidelines/2025-11-06T14:11:27+00:00weekly0.7https://www.medthority.com/guidelines/acute-coronary-syndrome/cvit-expert-consensus-document-on-primary-percutaneous-coronary-intervention-pci-for-acute-coronary-syndromes-acs-in-2024/2025-06-02T14:57:05+00:00weekly0.7https://www.medthority.com/guidelines/acute-hepatic-porphyrias/canadian-guidance-for-diagnosis-and-management-of-acute-hepatic-porphyrias/2025-06-03T10:20:31+00:00weekly0.7https://www.medthority.com/guidelines/acute-renal-failure/aga-clinical-practice-update-on-the-evaluation-and-management-of-acute-kidney-injury-in-patients-with-cirrhosis-expert-review/2025-06-03T13:36:29+00:00weekly0.7https://www.medthority.com/guidelines/adhd/the-world-federation-of-adhd-international-consensus-statement-208-evidence-based-conclusions-about-the-disorder/2025-06-03T14:08:35+00:00weekly0.7https://www.medthority.com/guidelines/adhd/attention-deficithyperactivity-disorder-in-pregnancy-and-the-postpartum-period/2025-06-03T14:33:43+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/eso-guideline-on-aphasia-rehabilitation/2025-05-27T11:11:04+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/eso-expedited-recommendation-on-tenecteplase-for-acute-ischaemic-stroke/2025-05-27T11:20:06+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/ahaasa-2024-guideline-for-the-primary-prevention-of-stroke/2025-05-27T12:58:20+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/germline-and-somatic-genomic-testing-for-metastatic-prostate-cancer-asco-guideline/2025-05-20T08:19:20+00:00weekly0.7https://www.medthority.com/guidelines/al-amyloidosis/al-amyloidosis-singapore-myeloma-study-group-consensus-guidelines-on-diagnosis-treatment-and-management/2025-06-10T09:48:43+00:00weekly0.7https://www.medthority.com/guidelines/al-amyloidosis/supportive-care-for-systemic-amyloidosis-international-society-of-amyloidosis-isa-expert-panel-guidelines/2025-06-10T10:30:46+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/a-practical-guide-to-using-oral-janus-kinase-inhibitors-for-atopic-dermatitis-from-the-international-eczema-council/2025-06-12T13:11:31+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/guidelines-of-care-for-the-management-of-atopic-dermatitis-in-adults-with-phototherapy-and-systemic-therapies/2025-06-12T13:11:31+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/eaaci-guidelines-on-the-management-of-ige-mediated-food-allergy/2025-06-12T13:23:36+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/eaaci-biologicals-guidelinesdupilumab-for-children-and-adults-with-moderate-to-severe-atopic-dermatitis/2025-06-13T09:17:06+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/bsaci-guidance-for-the-implementation-of-palforzia-peanut-oral-immunotherapy-in-the-united-kingdom-a-delphi-consensus-study/2025-06-16T12:46:25+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/bad-living-guideline-for-managing-people-with-alopecia-areata-2024/2025-07-07T09:29:37+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/diagnosis-and-management-of-lipid-transfer-protein-allergy---a-bsaci-clinical-practice-statement/2025-06-16T12:46:17+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/eaaci-biologicals-guidelines-omalizumab-for-the-treatment-of-csu-in-adults-and-in-the-paediatric-population-1217-years-old/2025-06-13T09:20:53+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/british-association-of-dermatologists-guidelines-for-the-management-of-people-with-chronic-urticaria-2021/2025-06-13T09:47:05+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/anaphylaxis-a-2023-practice-parameter-update/2025-06-16T09:13:26+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/eaaci-guidelines-anaphylaxis-2021-update/2025-06-16T09:33:32+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/aaaai-eaaci-practall-standardizing-oral-food-challenges-2024-update/2025-06-16T09:52:43+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/adrenaline-auto-injector-prescription-for-patients-at-risk-of-anaphylaxis-bsaci-guidance-for-primary-care/2025-06-16T12:53:53+00:00weekly0.7https://www.medthority.com/guidelines/allergic-rhinitis/kaaaci-allergic-rhinitis-guidelines-part-1.-update-in-pharmacotherapy2025-06-16T14:32:35+00:00weekly0.7https://www.medthority.com/guidelines/allergic-rhinitis/kaaaci-allergic-rhinitis-guidelines-part-2.-update-in-non-pharmacological-management2025-06-16T15:03:20+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/acg-clinical-guideline-diagnosis-and-management-of-eosinophilic-esophagitis/2025-05-19T13:15:07+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/diagnosis-and-management-of-eosinophilic-esophagitis-in-children-an-update-from-the-espghan/2025-05-05T14:48:09+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/s2k-guideline-gastroesophageal-reflux-disease-and-eosinophilic-esophagitis-of-the-german-society-of-gastroenterology-digestive-and-metabolic-diseases-dgvs/2025-01-20T13:37:28+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/pan-asian-adapted-esmo-clinical-practice-guidelines-for-the-diagnosis-treatment-and-follow-up-of-patients-with-prostate-cancer/2026-03-10T13:20:50+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/the-1st-eoetaly-consensus-on-the-diagnosis-and-management-of-eosinophilic-esophagitis---definition-clinical-presentation-and-diagnosis/2025-09-30T15:16:32+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/the-1st-eoetaly-consensus-on-the-diagnosis-and-management-of-eosinophilic-esophagitis---current-treatment-and-monitoring/2025-01-21T10:06:03+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/parp-inhibitors-in-the-management-of-ovarian-cancer-asco-guideline-rapid-recommendation-update/2025-05-22T07:50:10+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/neoadjuvant-chemotherapy-for-newly-diagnosed-advanced-ovarian-cancer-asco-guideline-update/2025-05-22T08:23:12+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/assessment-of-adult-women-with-ovarian-masses-and-treatment-of-epithelial-ovarian-cancer-asco-resource-stratified-guideline/2025-05-22T08:22:01+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/2023-isth-update-of-the-2022-isth-guidelines-for-antithrombotic-treatment-in-covid-19/2025-05-22T07:54:19+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/monitoring-patients-with-eosinophilic-esophagitis-in-routine-clinical-practice/2025-09-30T15:10:57+00:00weekly0.7https://www.medthority.com/guidelines/hlhmas/diagnosis-and-investigation-of-suspected-haemophagocytic-lymphohistiocytosis-in-adults-2023-hihasc-consensus-guideline/2025-03-27T09:48:53+00:00weekly0.7https://www.medthority.com/guidelines/hlhmas/consensus-based-guidelines-for-the-recognition-diagnosis-and-management-of-hemophagocytic-lymphohistiocytosis-in-critically-ill-children-and-adults/2025-03-27T09:57:51+00:00weekly0.7https://www.medthority.com/guidelines/hlhmas/diagnostic-guidelines-for-familial-hemophagocytic-lymphohistiocytosis-revisited/2025-03-27T09:55:42+00:00weekly0.7https://www.medthority.com/guidelines/cidp/european-academy-of-neurologyperipheral-nerve-society-guideline-on-diagnosis-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy/2025-03-18T13:49:02+00:00weekly0.7https://www.medthority.com/guidelines/cidp/french-recommendations-for-the-management-of-adult--pediatric-cidp/2025-03-18T14:33:25+00:00weekly0.7https://www.medthority.com/guidelines/cidp/current-clinical-management-of-cidp-with-immunoglobulins-in-france-an-expert-opinion/2025-03-18T14:58:00+00:00weekly0.7https://www.medthority.com/guidelines/hlhmas/challenges-in-the-diagnosis-of-hemophagocytic-lymphohistiocytosis-recommendations-from-the-nacho/2025-03-27T15:19:30+00:00weekly0.7https://www.medthority.com/guidelines/hlhmas/recommendations-for-the-management-of-hemophagocytic-lymphohistiocytosis-in-adults/2025-03-27T15:56:31+00:00weekly0.7https://www.medthority.com/guidelines/hlhmas/2016-classification-criteria-for-macrophage-activation-syndrome-complicating-systemic-juvenile-idiopathic-arthritis-a-eular-acr-printo/2025-03-27T16:21:32+00:00weekly0.7https://www.medthority.com/guidelines/hlhmas/the-2022-eularacr-points-to-consider-at-the-early-stages-of-diagnosis-and-management-of-suspected-haemophagocytic-lymphohistiocytosismacrophage-activation-syndrome-hlhmas/2025-03-27T09:58:21+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/kdigo-2024-clinical-practice-guideline-for-the-management-of-lupus-nephritis/2025-10-14T10:17:02+00:00weekly0.7https://www.medthority.com/guidelines/chronic-obstructive-pulmonary-disease-copd-and-bronchiectasis/pulmonary-rehabilitation-for-adults-with-chronic-respiratory-disease-an-official-american-thoracic-society-clinical-practice-guideline/2025-09-19T09:42:17+00:00weekly0.7https://www.medthority.com/guidelines/chronic-obstructive-pulmonary-disease-copd-and-bronchiectasis/2023-canadian-thoracic-society-guideline-on-pharmacotherapy-in-patients-with-stable-copd/2025-09-19T10:11:11+00:00weekly0.7https://www.medthority.com/guidelines/chronic-obstructive-pulmonary-disease-copd-and-bronchiectasis/pharmacologic-management-of-copd-an-official-ats-clinical-practice-guideline/2025-09-19T09:59:17+00:00weekly0.7https://www.medthority.com/guidelines/chronic-obstructive-pulmonary-disease-copd-and-bronchiectasis/long-term-noninvasive-ventilation-in-chronic-stable-hypercapnic-copd-an-official-ats-clinical-practice-guideline/2025-11-10T10:50:10+00:00weekly0.7https://www.medthority.com/guidelines/growth-hormone-deficiency/shared-care-guidelines-for-paediatric-use-of-daily-and-long-acting-recombinant-human-growth-hormone/2025-10-16T08:11:14+00:00weekly0.7https://www.medthority.com/guidelines/growth-hormone-deficiency/bsped-recommendations-for-the-use-of-once-weekly-long-acting-growth-hormone-therapy-in-children-with-growth-hormone-deficiency/2025-10-16T08:02:43+00:00weekly0.7https://www.medthority.com/guidelines/growth-hormone-deficiency/aaceace-guidelines-for-management-of-growth-hormone-deficiency-in-adults-and-patients-transitioning-from-pediatric-to-adult-care/2025-10-14T15:15:39+00:00weekly0.7https://www.medthority.com/guidelines/growth-hormone-deficiency/diagnosis-genetics-and-therapy-of-short-stature-in-children-a-growth-hormone-research-society-international-perspective/2025-10-14T15:01:28+00:00weekly0.7https://www.medthority.com/guidelines/pompe-disease/start-switch-and-stop-triple-s-criteria-for-enzyme-replacement-therapy-of-late-onset-pompe-disease-european-pompe-consortium-recommendation-update-2024/2026-03-09T15:34:03+00:00weekly0.7https://www.medthority.com/guidelines/cushings-syndrome/consensus-on-diagnosis-and-management-of-cushings-disease-a-guideline-update/2025-09-25T09:23:09+00:00weekly0.7https://www.medthority.com/guidelines/cushings-syndrome/consensus-statement-by-the-french-society-of-endocrinology-sfe-and-french-society-of-pediatric-endocrinology--diabetology-sfedp-for-the-diagnosis-of-cushings-syndrome-genetics-of-cushings-syndrome/2025-09-25T11:51:20+00:00weekly0.7https://www.medthority.com/guidelines/congestive-heart-failure/2022-ahaacchfsa-guideline-for-the-management-of-heart-failure/2025-02-24T15:19:22+00:00weekly0.7https://www.medthority.com/guidelines/congestive-heart-failure/2023-focused-update-of-the-2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure/2025-02-24T15:23:34+00:00weekly0.7https://www.medthority.com/guidelines/headache/international-headache-society-global-practice-recommendations-for-the-acute-pharmacological-treatment-of-migraine/2025-10-16T09:09:02+00:00weekly0.7https://www.medthority.com/guidelines/headache/international-headache-society-global-practice-recommendations-for-preventive-pharmacological-treatment-of-migraine/2025-10-16T09:08:27+00:00weekly0.7https://www.medthority.com/guidelines/headache/migraine-treatment-position-paper-of-the-french-headache-society/2025-10-16T09:02:57+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/consensus-statement-of-the-spanish-society-of-neurology-on-the-treatment-of-multiple-sclerosis-and-holistic-patient-management-in-2023/2025-01-13T09:21:38+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/european-academy-of-neurologymovement-disorder-society---european-section-guideline-on-the-treatment-of-parkinsons-disease-i.-invasive-therapies2025-02-24T15:06:45+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/physical-therapist-management-of-parkinson-disease-a-clinical-practice-guideline-from-the-american-physical-therapy-association/2025-02-24T15:27:09+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/pharmacotherapy-of-motor-symptoms-in-early-and-mid-stage-parkinsons-disease-guideline-parkinsons-disease-of-the-german-society-of-neurology/2025-01-13T09:21:46+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/german-society-of-neurology-guidelines-for-the-diagnosis-and-treatment-of-cognitive-impairment-and-affective-disorders-in-people-with-parkinsons-disease-new-spotlights-on-diagnostic-procedures-and-non-pharmacological-interventions/2025-01-13T09:21:45+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/diagnostics-and-treatment-of-impulse-control-disorders-psychosis-and-delirium-systemic-review-based-recommendations---guideline-parkinsons-disease-of-the-german-society-of-neurology/2025-01-13T09:21:45+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/guideline-parkinsons-disease-of-the-german-society-of-neurology-deutsche-gesellschaft-fur-neurologie-concepts-of-care/2025-01-13T09:21:45+00:00weekly0.7https://www.medthority.com/guidelines/parkinsons-disease/systematic-review-based-guideline-parkinsons-disease-of-the-german-society-of-neurology-diagnostic-use-of-transcranial-sonography/2025-01-13T09:21:45+00:00weekly0.7https://www.medthority.com/guidelines/hypertension/2024-esc-guidelines-for-the-management-of-elevated-blood-pressure-and-hypertension/2025-02-24T15:29:05+00:00weekly0.7https://www.medthority.com/guidelines/hypertension/2024-european-society-of-hypertension-clinical-practice-guidelines-for-the-management-of-arterial-hypertension/2025-10-28T14:28:14+00:00weekly0.7https://www.medthority.com/guidelines/adhd/sdbp-clinical-practice-guideline-for-the-assessment-and-treatment-of-children-and-adolescents-with-complex-adhd/2025-05-27T07:49:11+00:00weekly0.7https://www.medthority.com/guidelines/myasthenia-gravis/international-consensus-guidance-for-management-of-myasthenia-gravis-2020-update/2026-02-05T15:26:43+00:00weekly0.7https://www.medthority.com/guidelines/myasthenia-gravis/practice-advisory-thymectomy-for-myasthenia-gravis-practice-parameter-update/2026-02-05T14:45:05+00:00weekly0.7https://www.medthority.com/guidelines/myasthenia-gravis/the-japanese-clinical-guidelines-2022-for-myasthenia-gravis-and-lamberteaton-myasthenic-syndrome/2026-02-05T14:32:57+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/ectrimsean-consensus-on-vaccination-in-people-with-multiple-sclerosis-improving-immunization-strategies-in-the-era-of-highly-active-immunotherapeutic-drugs/2026-01-09T09:44:47+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/ectrimsean-guideline-on-the-pharmacological-treatment-of-people-with-multiple-sclerosis/2026-01-09T10:03:14+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/urinary-tract-infections-and-multiple-sclerosis-recommendations-from-the-french-multiple-sclerosis-society/2026-01-09T09:33:14+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/infections-and-multiple-sclerosis-recommendations-from-the-french-multiple-sclerosis-society/2026-01-09T09:26:31+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/how-to-switch-disease-modifying-treatments-in-multiple-sclerosis-guidelines-from-the-french-multiple-sclerosis-society-sfsep/2026-01-09T09:20:21+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/practice-guideline-recommendations-summary-disease-modifying-therapies-for-adults-with-multiple-sclerosis/2026-01-09T09:14:33+00:00weekly0.7https://www.medthority.com/guidelines/al-amyloidosis/guidelines-for-high-dose-chemotherapy-and-stem-cell-transplantation-for-systemic-al-amyloidosis-eha-isa-working-group-guidelines/2025-02-21T09:47:27+00:00weekly0.7https://www.medthority.com/guidelines/al-amyloidosis/guidelines-for-non-transplant-chemotherapy-for-treatment-of-systemic-al-amyloidosis-eha-isa-working-group/2025-02-21T09:49:41+00:00weekly0.7https://www.medthority.com/guidelines/multiple-sclerosis/diagnosis-and-treatment-of-progressive-multiple-sclerosis-a-position-paper/2026-01-09T09:08:36+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/aga-clinical-practice-guideline-on-the-role-of-biomarkers-for-the-management-of-ulcerative-colitis/2025-02-21T09:59:21+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/aga-clinical-practice-update-on-management-of-inflammatory-bowel-disease-in-elderly-patients-expert-review/2025-02-21T10:07:00+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/aga-clinical-practice-guidelines-on-the-management-of-moderate-to-severe-ulcerative-colitis/2025-02-21T10:16:26+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/acg-clinical-guideline-ulcerative-colitis-in-adults/2025-02-21T10:19:32+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/bsg-consensus-guidelines-on-the-management-of-inflammatory-bowel-disease-in-adults/2025-01-13T09:21:50+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/genomic-diagnosis-and-care-co-ordination-for-monogenic-inflammatory-bowel-disease-in-children-and-adults-consensus-guideline-on-behalf-of-the-british-society-of-gastroenterology-and-british-society-of-paediatric-gastroenterology-hepatology-and-nutrition/2025-02-21T10:42:09+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/update-of-the-pancco-clinical-practice-guidelines-for-the-treatment-of-ulcerative-colitis-in-the-adult-population/2025-01-13T09:21:49+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/the-american-society-of-colon-and-rectal-surgeons-clinical-practice-guidelines-for-the-surgical-management-of-ulcerative-colitis/2025-02-21T10:53:20+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-surgical-treatment/2025-01-13T09:21:52+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/ecco-guidelines-on-therapeutics-in-ulcerative-colitis-medical-treatment/2025-01-13T09:21:52+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/ecco-guidelines-on-the-prevention-diagnosis-and-management-of-infections-in-inflammatory-bowel-disease/2025-01-13T09:21:52+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/european-crohns-and-colitis-guidelines-on-sexuality-fertility-pregnancy-and-lactation/2025-01-13T09:21:51+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-1-initial-diagnosis-monitoring-of-known-ibd-detection-of-complications/2025-01-13T09:21:51+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/ecco-esgar-guideline-for-diagnostic-assessment-in-ibd-part-2-ibd-scores-and-general-principles-and-technical-aspects/2025-01-13T09:21:51+00:00weekly0.7https://www.medthority.com/guidelines/allergic-rhinitis/bsaci-guideline-for-the-diagnosis-and-management-of-allergic-and-non-allergic-rhinitis/2025-06-16T13:14:38+00:00weekly0.7https://www.medthority.com/guidelines/allergic-rhinitis/eaaci-guidelines-on-allergen-immunotherapy-allergic-rhinoconjunctivitis/2025-06-16T13:30:33+00:00weekly0.7https://www.medthority.com/guidelines/allergic-rhinitis/next-generation-allergic-rhinitis-and-its-impact-on-asthma-aria-guidelines-for-allergic-rhinitis-based-on-grading-of-recommendations-assessment-development-and-evaluation-grade-and-real-world-evidence/2025-06-16T13:54:28+00:00weekly0.7https://www.medthority.com/guidelines/allergic-rhinitis/japanese-guidelines-for-allergic-rhinitis-2020/2025-06-16T13:44:09+00:00weekly0.7https://www.medthority.com/guidelines/cystinosis/management-of-bone-disease-in-cystinosis-statement-from-an-international-conference/2025-11-10T11:16:54+00:00weekly0.7https://www.medthority.com/guidelines/cystinosis/expert-guidance-on-the-multidisciplinary-management-of-cystinosis-in-adolescent-and-adult-patients/2025-11-10T11:13:51+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/tissue-biopsy-for-the-diagnosis-of-amyloidosis-experience-from-some-centres/2025-10-21T10:46:27+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/expert-consensus-recommendations-for-the-suspicion-and-diagnosis-of-transthyretin-cardiac-amyloidosis/2025-10-21T10:42:50+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/2023-acc-expert-consensus-decision-pathway-on-comprehensive-multidisciplinary-care-for-the-patient-with-cardiac-amyloidosis/2025-10-21T10:39:00+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/diagnosis-and-treatment-of-cardiac-amyloidosis-a-position-statement-of-the-esc-working-group-on-myocardial-and-pericardial-diseases/2025-10-21T10:31:14+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/avoiding-misdiagnosis-expert-consensus-recommendations-for-the-suspicion-and-diagnosis-of-transthyretin-amyloidosis-for-the-general-practitioner/2025-10-21T10:28:29+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/management-of-transthyretin-amyloidosis-guidelines-from-the-1st-swiss-amyloidosis-network-san-consensus-conference/2025-10-21T12:21:22+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/clinical-recommendations-to-diagnose-and-monitor-patients-with-transthyretin-amyloid-cardiomyopathy-in-asia/2025-10-21T12:21:38+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/screening-for-lung-cancer-2023-guideline-update-from-the-american-cancer-society/2025-11-04T13:50:01+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/consensus-recommendations-on-holistic-care-in-hereditary-attr-amyloidosis-an-international-delphi-survey-of-patient-advocates-and-multidisciplinary-healthcare-professionals/2025-10-21T12:21:56+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/esmo-expert-consensus-statements-on-on-the-definition-diagnosis-and-management-of-her2-low-breast-cancer/2025-11-10T10:17:17+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/esmo-clinical-practice-guideline-for-the-diagnosis-staging-and-treatment-of-patients-with-metastatic-breast-cancer/2025-11-10T10:19:07+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/risk-reduction-and-screening-of-cancer-in-hereditary-breast-ovarian-cancer-syndromes-esmo-clinical-practice-guideline/2025-11-10T10:18:12+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/esoesmo-fifth-international-consensus-guidelines-for-breast-cancer-in-young-women-bcy5/2025-08-12T13:20:08+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/esmo-expert-consensus-statements-on-the-management-of-breast-cancer-during-pregnancy-prbc/2025-11-10T10:17:39+00:00weekly0.7https://www.medthority.com/guidelines/acute-hepatic-porphyrias/aga-clinical-practice-update-on-diagnosis-and-management-of-acute-hepatic-porphyrias-expert-review/2025-06-02T15:15:58+00:00weekly0.7https://www.medthority.com/guidelines/acute-hepatic-porphyrias/expert-consensus-statement-on-acute-hepatic-porphyria-in-belgium/2025-06-03T10:50:09+00:00weekly0.7https://www.medthority.com/guidelines/acute-hepatic-porphyrias/acute-hepatic-porphyrias-recommendations-for-diagnosis-and-management-with-real-world-examples/2025-06-03T10:24:55+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/ecco-guidelines-on-therapeutics-in-crohns-disease-medical-treatment/2025-01-13T09:21:49+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/ecco-guidelines-on-therapeutics-in-crohns-disease-surgical-treatment/2025-01-13T09:21:49+00:00weekly0.7https://www.medthority.com/guidelines/regional-enteritis-and-ulcerative-colitis/the-medical-management-of-paediatric-crohns-disease-an-ecco-espghan-guideline-update/2025-01-13T09:21:49+00:00weekly0.7https://www.medthority.com/guidelines/primary-hyperoxaluria-type-1/clinical-practice-recommendations-for-primary-hyperoxaluria-an-expert-consensus-statement-from-erknet-and-oxaleurope/2026-03-09T16:18:42+00:00weekly0.7https://www.medthority.com/guidelines/atrial-fibrillation/new-onset-atrial-fibrillation-in-critically-ill-adult-patients-an-ssai-clinical-practice-guideline/2025-11-10T10:14:11+00:00weekly0.7https://www.medthority.com/guidelines/hereditary-transthyretin-amyloidosis-hattr/guidelines-and-new-directions-in-the-therapy-and-monitoring-of-attrv-amyloidosis/2025-10-21T12:20:22+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/management-of-older-patients-with-frailty-and-acute-myeloid-leukaemia-a-bsh-good-practice-paper/2025-10-30T10:55:56+00:00weekly0.7https://www.medthority.com/guidelines/acute-coronary-syndrome/2023-esc-guidelines-for-the-management-of-acute-coronary-syndromes/2025-05-27T13:25:32+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/addendum-to-guidelines-on-the-investigation-and-management-of-venous-thrombosis-at-unusual-sites-use-of-direct-oral-anticoagulants/2025-02-13T10:03:41+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/venous-thromboembolism-in-cancer-patients-esmo-clinical-practice-guideline/2025-01-13T09:21:54+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/endoscopic-approach-to-eosinophilic-esophagitis-american-society-for-gastrointestinal-endoscopy-consensus-conference/2025-11-10T11:41:04+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/a-clinical-severity-index-for-eosinophilic-esophagitis-development-consensus-and-future-directions/2025-10-02T08:07:31+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/alopecia-areata--current-understanding-and-management/2025-11-06T15:36:57+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/alopecia-areata-current-understanding-of-the-pathophysiology-and-update-on-therapeutic-approaches-featuring-the-japanese-dermatological-association-guidelines/2025-11-06T15:07:26+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/the-alopecia-areata-consensus-of-experts-ace-study-results-of-an-international-expert-opinion-on-treatments-for-alopecia-areata/2025-11-06T15:00:30+00:00weekly0.7https://www.medthority.com/guidelines/alopecia-areata/the-alopecia-areata-consensus-of-experts-ace-study-part-ii-results-of-an-international-expert-opinion-on-diagnosis-and-laboratory-evaluation-for-alopecia-areata/2025-11-06T14:49:51+00:00weekly0.7https://www.medthority.com/guidelines/headache/european-headache-federation-guideline-on-the-use-of-monoclonal-antibodies-targeting-the-calcitonin-gene-related-peptide-pathway-for-migraine-prevention--2022-update/2025-10-16T11:15:45+00:00weekly0.7https://www.medthority.com/guidelines/headache/the-american-headache-society-consensus-statement-update-on-integrating-new-migraine-treatments-into-clinical-practice/2025-10-16T11:02:29+00:00weekly0.7https://www.medthority.com/guidelines/headache/practice-guideline-update-summary-acute-treatment-of-migraine-in-children-and-adolescents/2025-10-16T10:31:35+00:00weekly0.7https://www.medthority.com/guidelines/headache/practice-guideline-update-summary-pharmacologic-treatment-for-pediatric-migraine-prevention/2025-10-16T10:28:10+00:00weekly0.7https://www.medthority.com/guidelines/chronic-cough/ers-guidelines-on-the-diagnosis-and-treatment-of-chronic-cough-in-adults-and-children/2025-09-16T13:32:34+00:00weekly0.7https://www.medthority.com/guidelines/chronic-cough/german-respiratory-society-guidelines-for-diagnosis-and-treatment-of-adults-suffering-from-acute-subacute-and-chronic-cough/2025-09-16T13:06:14+00:00weekly0.7https://www.medthority.com/guidelines/chronic-cough/chronic-cough-due-to-gastroesophageal-reflux-in-adults-chest-guideline-and-expert-panel-report-2016/2025-11-10T10:47:58+00:00weekly0.7https://www.medthority.com/guidelines/chronic-cough/managing-chronic-cough-due-to-asthma-and-naeb-in-adults-and-adolescents-chest-guideline-and-expert-panel-report-2020/2025-11-10T10:47:09+00:00weekly0.7https://www.medthority.com/guidelines/chronic-cough/chronic-cough-due-to-stable-chronic-bronchitis-chest-expert-panel-report-2020/2025-11-10T10:46:25+00:00weekly0.7https://www.medthority.com/guidelines/chronic-cough/managing-chronic-cough-as-a-symptom-in-children-and-management-algorithms-chest-guideline-and-expert-panel-report-2020/2025-09-16T09:55:48+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/eaaci-guidelines-on-the-diagnosis-of-ige-mediated-food-allergy/2025-06-12T13:11:32+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/the-international-eaacigaleneuroguidermapaaaci-guideline-for-the-definition-classification-diagnosis-and-management-of-urticaria/2025-06-13T08:59:09+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/menopause-wellbeing-and-health-a-care-pathway-from-the-european-menopause-and-andropause-society/2025-11-27T10:21:54+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/menopause-symptom-management-in-women-with-dyslipidemias-an-emas-clinical-guide/2025-11-27T10:09:36+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/clinical-practice-guidelines-for-managing-genitourinary-symptoms-associated-with-menopause/2025-11-25T15:48:30+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/the-management-of-newly-diagnosed-large-b-cell-lymphoma-a-british-society-for-haematology-guideline/2026-02-16T15:32:01+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/diagnosis-and-management-of-mantle-cell-lymphoma-a-british-society-for-haematology-guideline/2026-02-16T16:04:42+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/canadian-evidence-based-guideline-for-the-frontline-treatment-of-diffuse-large-b-cell-lymphoma/2026-02-16T15:49:28+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/canadian-evidence-based-guideline-for-the-treatment-of-relapsedrefractory-diffuse-large-b-cell-lymphoma/2026-02-16T15:43:05+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/guideline-for-the-diagnosis-and-management-of-marginal-zone-lymphomas-a-british-society-of-haematology-guideline/2026-02-16T15:24:05+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/guidelines-for-the-management-of-mature-t--and-natural-killer-cell-lymphomas-excluding-cutaneous-t-cell-lymphoma/2026-02-10T15:07:46+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/management-of-postmenopausal-women-college-national-des-gynecologues-et-obstetriciens-francais-cngof-and-groupe-detude-sur-la-menopause-et-le-vieillissement-gemvi-clinical-practice-guidelines/2025-11-25T15:33:56+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/the-british-menopause-society--womens-health-concern-2020-recommendations-on-hormone-replacement-therapy-in-menopausal-women/2025-11-25T15:17:26+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/joint-position-statement-by-the-british-menopause-society-royal-college-of-obstetricians-and-gynaecologists-and-society-for-endocrinology-on-best-practice-recommendations-for-the-care-of-women-experiencing-the-menopause/2025-11-25T14:49:40+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/the-2023-nonhormone-therapy-position-statement-of-the-north-american-menopause-society/2025-11-25T14:28:00+00:00weekly0.7https://www.medthority.com/guidelines/menopausal-disorders/the-2022-hormone-therapy-position-statement-of-the-north-american-menopause-society/2025-11-25T14:22:31+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/consensus-based-guidelines-for-the-provision-of-palliative-and-end-of-life-care-for-people-living-with-epidermolysis-bullosa/2025-10-02T09:50:11+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/neonatal-epidermolysis-bullosa-a-clinical-practice-guideline/2025-10-02T09:45:52+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/emergency-management-in-epidermolysis-bullosa-consensus-clinical-recommendations-from-the-european-reference-network-for-rare-skin-diseases/2025-10-02T09:42:13+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/practical-management-of-epidermolysis-bullosa-consensus-clinical-position-statement-from-the-european-reference-network-for-rare-skin-diseases/2025-10-02T09:40:22+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/consensus-guidelines-for-diagnosis-and-management-of-anemia-in-epidermolysis-bullosa/2025-10-02T09:29:32+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/physiotherapy-for-epidermolysis-bullosa-clinical-practice-guidelines/2025-10-02T09:25:20+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/foot-care-in-epidermolysis-bullosa-evidence-based-guideline/2025-10-02T09:17:44+00:00weekly0.7https://www.medthority.com/guidelines/epidermolysis-bullosa/hand-surgery-and-hand-therapy-clinical-practice-guideline-for-epidermolysis-bullosa/2025-10-02T09:08:33+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/atopic-dermatitis-eczema-guidelines-2023-american-academy-of-allergy-asthma-and-immunologyamerican-college-of-allergy-asthma-and-immunology-joint-task-force-on-practice-parameters-grade--and-institute-of-medicine-based-recommendations/2025-06-12T13:11:32+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/guidelines-for-diagnosis-prevention-and-treatment-of-hand-eczema/2025-11-27T11:48:55+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/chronic-hand-eczema-guidelines-from-an-expert-panel-of-the-international-eczema-council/2025-11-06T14:31:32+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/s2k-guideline-diagnosis-prevention-and-therapy-of-hand-eczema/2025-06-12T13:11:31+00:00weekly0.7https://www.medthority.com/guidelines/alpha-1-antitrypsin-deficiency/the-diagnosis-and-management-of-alpha-1-antitrypsin-deficiency-in-the-adult-alpha-1-foundation/2025-11-06T15:46:28+00:00weekly0.7https://www.medthority.com/guidelines/supraventricular-tachycardia/management-of-patients-with-supraventricular-tachycardia---2020-esc/2021-09-24T07:37:25+00:00weekly0.7https://www.medthority.com/guidelines/macular-degeneration/age-related-macular-degeneration-preferred-practice-pattern/2025-12-11T09:01:26+00:00weekly0.7https://www.medthority.com/guidelines/nasal-polyposis/euforea-expert-board-meeting-on-uncontrolled-severe-chronic-rhinosinusitis-with-nasal-polyps-crswnp-and-biologics-definitions-and-management/2026-02-09T14:01:43+00:00weekly0.7https://www.medthority.com/guidelines/nasal-polyposis/european-position-paper-on-rhinosinusitis-and-nasal-polyps-2020/2026-02-09T13:22:49+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/germline-and-somatic-tumor-testing-in-epithelial-ovarian-cancer-asco-guideline/2025-02-24T15:08:31+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/seom-clinical-guidelines-in-hereditary-breast-and-ovarian-cancer-2019/2026-03-03T16:14:46+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/parp-inhibitors-in-the-management-of-ovarian-cancer-asco-guideline/2025-05-22T08:30:19+00:00weekly0.7https://www.medthority.com/guidelines/systemic-lupus-erythematosus/2019-update-of-the-eular-recommendations-for-the-management-of-systemic-lupus-erythematosus/2021-09-24T07:37:26+00:00weekly0.7https://www.medthority.com/guidelines/mood-disorders/clinical-guidelines-for-the-management-of-treatment-resistant-depression-french-recommendations-from-experts-the-french-association-for-biological-psychiatry-and-neuropsychopharmacology-and-the-fondation-fondamental/2026-01-06T16:13:02+00:00weekly0.7https://www.medthority.com/guidelines/mood-disorders/consensus-paper-of-the-wfsbp-task-force-on-genetics-genetics-epigenetics-and-gene-expression-markers-of-major-depressive-disorder-and-antidepressant-response/2026-01-06T16:05:08+00:00weekly0.7https://www.medthority.com/guidelines/mood-disorders/monitoring-for-antidepressant-associated-adverse-events-in-the-treatment-of-patients-with-major-depressive-disorder-an-international-consensus-statement/2026-01-06T16:02:51+00:00weekly0.7https://www.medthority.com/guidelines/shingles/vaccination-against-herpes-zoster-virus-zona/2021-09-24T07:37:22+00:00weekly0.7https://www.medthority.com/guidelines/shingles/updated-recommendations-on-the-use-of-herpes-zoster-vaccines/2021-09-24T07:37:22+00:00weekly0.7https://www.medthority.com/guidelines/shingles/s2k-guidelines-for-the-diagnosis-and-treatment-of-herpes-zoster-and-postherpetic-neuralgia/2025-02-24T15:04:05+00:00weekly0.7https://www.medthority.com/guidelines/shingles/recommendations-of-the-advisory-committee-on-immunization-practices-for-use-of-herpes-zoster-vaccines/2021-09-24T07:37:22+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/nccn-guidelines-insights-cancer-associated-venous-thromboembolic-disease/2022-03-15T15:15:29+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/treatment-and-prophylaxis-of-venous-thromboembolism-in-patients-with-cancer/2025-05-22T09:52:05+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/venous-thromboembolism-prophylaxis-and-treatment-in-patients-with-cancer-asco/2025-05-19T13:12:38+00:00weekly0.7https://www.medthority.com/guidelines/shingles/european-consensus-based-s2k-guideline-on-the-management-of-herpes-zosterguided-by-the-europeandermatology-forum-edf-in-cooperation-with-the-europeanacademy-of-dermatology-and-venereology-eadv-part-1diagnosis/2024-02-27T16:44:57+00:00weekly0.7https://www.medthority.com/guidelines/shingles/european-consensus-based-s2k-guideline-on-the-management-of-herpes-zoster--guided-by-the-european-dermatology-forum-edf-in-cooperation-with-the-european-academy-of-dermatology-and-venereology-eadv-part-2-treatment/2024-03-08T11:41:00+00:00weekly0.7https://www.medthority.com/guidelines/amyloid-transthyretin-attr-amyloidosis/expert-consensus-recommendations-to-improve-diagnosis-of-attr-amyloidosis-with-polyneuropathy/2025-11-07T09:29:47+00:00weekly0.7https://www.medthority.com/guidelines/amyloid-transthyretin-attr-amyloidosis/expert-consensus-recommendations-for-the-suspicion-and-diagnosis-of-transthyretin-cardiac-amyloidosis/2025-11-07T09:21:18+00:00weekly0.7https://www.medthority.com/guidelines/amyloid-transthyretin-attr-amyloidosis/patisiran-for-treating-hereditary-transthyretin-amyloidosis/2025-11-07T09:15:10+00:00weekly0.7https://www.medthority.com/guidelines/amyloid-transthyretin-attr-amyloidosis/inotersen-for-treating-hereditary-transthyretin-amyloidosis/2025-11-07T09:05:39+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/bhiva-bashh-bia-adult-hiv-testing-guidelines/2025-10-23T10:47:00+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/british-hiv-association-guidelines-on-the-management-of-opportunistic-infection-in-people-living-with-hiv-the-clinical-management-of-gastrointestinal-opportunistic-infections-2020/2025-10-23T14:12:58+00:00weekly0.7https://www.medthority.com/guidelines/hiv-infection/british-hiv-association-guidelines-on-the-management-of-opportunistic-infection-in-people-living-with-hiv-the-clinical-management-of-candidiasis-2019/2025-10-23T14:04:12+00:00weekly0.7https://www.medthority.com/guidelines/solid-organ-transplantation/post-operative-care-in-the-kidney-transplant-recipient/2023-05-30T11:48:59+00:00weekly0.7https://www.medthority.com/guidelines/solid-organ-transplantation/standardisation-of-immunosuppressive-and-anti-infective-drug-regimens-in-uk-paediatric-renal-transplantation-the-harmonisation-programme/2025-02-06T15:52:25+00:00weekly0.7https://www.medthority.com/guidelines/solid-organ-transplantation/easl-clinical-practice-guidelines--liver-transplantation/2023-05-30T12:40:23+00:00weekly0.7https://www.medthority.com/guidelines/hidradenitis-suppurativa/north-american-clinical-management-guidelines-for-hidradenitis-suppurativa-a-publication-from-the-united-states-and-canadian-hidradenitis-suppurativa-foundations-part-i-diagnosis-evaluation-and-the-use-of-complementary-and-procedural-management/2025-11-06T14:03:10+00:00weekly0.7https://www.medthority.com/guidelines/hidradenitis-suppurativa/north-american-clinical-management-guidelines-for-hidradenitis-suppurativa-a-publication-from-the-united-states-and-canadian-hidradenitis-suppurativa-foundations-part-ii-topical-intralesional-and-systemic-medical-management/2025-11-06T13:58:12+00:00weekly0.7https://www.medthority.com/guidelines/chronic-kidney-disease/kdoqi-clinical-practice-guideline-for-nutrition-in-ckd-2020-update/2025-09-19T08:36:37+00:00weekly0.7https://www.medthority.com/guidelines/chronic-kidney-disease/kdigo-2017-chronic-kidney-diseasemineral-and-bone-disorder/2025-09-19T08:36:37+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/2019-european-thyroid-association-guidelines-for-the-treatment-and-follow-up-of-advanced-radioiodine-refractory-thyroid-cancer/2021-09-24T07:37:27+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/2021-american-thyroid-association-guidelines-for-management-of-patients-with-anaplastic-thyroid-cancer/2025-05-20T12:25:19+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/management-guidelines-for-children-with-thyroid-nodules-and-differentiated-thyroid-cancer/2025-05-22T10:16:05+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/management-guidelines-for-adult-patients-with-thyroid-nodules-and-differentiated-thyroid-cancer/2025-05-20T09:58:24+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/the-american-association-of-endocrine-surgeons-guidelines-for-the-definitive-surgical-management-of-thyroid-disease-in-adults/2025-05-22T10:13:26+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/controversies-consensus-and-collaboration-in-the-use-of-radioiodine-therapy-in-differentiated-thyroid-cancer-a-joint-statement-from-the-ata-the-eanm-the-snmmi-and-the-eta/2025-05-20T12:32:33+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/adjuvant-systemic-therapy-and-adjuvant-radiation-therapy-for-stage-i-to-iiia-completely-resected-nonsmall-cell-lung-cancers-american-society-of-clinical-oncologycancer-care-ontario-clinical-practice-guideline-update/2025-12-01T16:03:27+00:00weekly0.7https://www.medthority.com/guidelines/retinal-dystrophies/recommendations-on-clinical-assessment-of-patients-with-inherited-retinal-degenerations---2016/2025-01-13T09:21:53+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/anaphylaxis-assessment-and-referral-after-emergency-treatment/2025-06-16T08:20:50+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/addendum-guidelines-for-the-prevention-of-peanut-allergy-in-the-united-states---report-of-the-niaid-sponsored-expert-panel/2025-11-06T14:34:14+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/european-society-for-vascular-surgery-esvs-2021-clinical-practice-guidelines-on-the-management-of-venous-thrombosis/2025-01-13T09:21:55+00:00weekly0.7https://www.medthority.com/guidelines/glaucoma/primary-open-angle-glaucoma-preferred-practice-pattern/2025-10-14T09:01:22+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/american-society-of-hematology-2021-guidelines-for-management-of-venous-thromboembolism-prevention-and-treatment-in-patients-with-cancer/2025-01-13T09:21:55+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/american-society-of-hematology-2018-guidelines-for-management-of-venous-thromboembolism-diagnosis-of-venous-thromboembolism/2025-01-13T09:21:55+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/american-society-of-hematology-2020-guidelines-for-management-of-venous-thromboembolism-treatment-of-deep-vein-thrombosis-and-pulmonary-embolism/2025-01-13T09:21:55+00:00weekly0.7https://www.medthority.com/guidelines/chronic-kidney-disease/recommendations-by-the-asian-pacific-society-of-nephrology-apsn-on-the-appropriate-use-of-hif-ph-inhibitors/2025-09-19T08:36:37+00:00weekly0.7https://www.medthority.com/guidelines/fluid-and-electrolyte-disorders/clinical-practice-guidelines-treatment-of-acute-hyperkalaemia-in-adults/2025-10-09T14:16:49+00:00weekly0.7https://www.medthority.com/guidelines/fluid-and-electrolyte-disorders/consensus-based-recommendations-for-the-management-of-hyperkalemia-in-the-hemodialysis-setting/2025-10-09T14:31:45+00:00weekly0.7https://www.medthority.com/guidelines/polycystic-kidney-disease/monitoring-children-and-young-people-with-or-at-risk-of-developing-autosomal-dominant-polycystic-kidney-disease-adpkd/2026-03-06T10:43:30+00:00weekly0.7https://www.medthority.com/guidelines/polycystic-kidney-disease/international-consensus-statement-on-the-diagnosis-and-management-of-autosomal-dominant-polycystic-kidney-disease-in-children-and-young-people/2026-03-06T09:50:24+00:00weekly0.7https://www.medthority.com/guidelines/polycystic-kidney-disease/european-adpkd-forum-multidisciplinary-position-statement-on-autosomal-dominant-polycystic-kidney-disease-care-european-adpkd-forum-and-multispecialist-roundtable-participants/2026-03-06T09:40:50+00:00weekly0.7https://www.medthority.com/guidelines/polycystic-kidney-disease/imaging-of-kidney-cysts-and-cystic-kidney-diseases-in-children-an-international-working-group-consensus-statement/2026-03-06T09:39:08+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/2019-update-of-the-joint-european-league-against-rheumatism-and-european-renal-association-european-dialysis-and-transplant-association-eularera-edta-recommendations-for-the-management-of-lupus-nephritis/2025-10-14T12:21:50+00:00weekly0.7https://www.medthority.com/guidelines/acute-coronary-syndrome/diagnosis-and-risk-stratification-of-chest-pain-patients-in-the-emergency-department-focus-on-acute-coronary-syndromes.-a-position-paper-of-the-acute-cardiovascular-care-association2025-06-03T10:32:04+00:00weekly0.7https://www.medthority.com/guidelines/acute-coronary-syndrome/2021-ahaaccasechestsaemscctscmr-guideline-for-the-evaluation-and-diagnosis-of-chest-pain/2025-11-06T14:13:11+00:00weekly0.7https://www.medthority.com/guidelines/eosinophilic-esophagitis/aga-institute-and-the-joint-task-force-on-allergy-immunology-practice-parameters-clinical-guidelines-for-the-management-of-eosinophilic-esophagitis/2025-11-10T11:42:32+00:00weekly0.7https://www.medthority.com/guidelines/respiratory-syncytial-virus-rsv/respiratory-syncytial-virus-rsv-in-preterm-and-ill-infants/2025-01-13T09:21:52+00:00weekly0.7https://www.medthority.com/guidelines/respiratory-syncytial-virus-rsv/respiratory-syncytial-virus-rsv-symptoms-transmission-prevention-treatment/2025-01-13T09:21:52+00:00weekly0.7https://www.medthority.com/guidelines/Cervical-cancer/cervical-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-15T15:20:29+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/bsaci-guideline-for-the-diagnosis-and-management-of-cows-milk-allergy/2025-06-16T08:23:51+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/guidelines-on-the-investigation-and-management-of-venous-thrombosis-at-unusual-sites/2025-02-13T10:11:24+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-bone-and-connective-tissue/bone-sarcomas--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-08-12T13:19:47+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-oesophagus/oesophageal-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-12T08:11:42+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/chronic-myeloid-leukemia--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-10-31T09:02:25+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/eular-recommendations-for-patient-education-for-people-with-inflammatory-arthritis/2023-05-31T13:31:32+00:00weekly0.7https://www.medthority.com/guidelines/chronic-kidney-disease/kdigo-clinical-practice-guideline-for-the-management-of-blood-pressure-in-chronic-kidney-disease/2025-09-19T08:36:37+00:00weekly0.7https://www.medthority.com/guidelines/pulmonary-heart-disease/esc-ers-guidelines-for-the-diagnosis-and-treatment-of-pulmonary-hypertension/2023-06-05T08:03:13+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-kidney-and-renal-pelvis/guidelines-on-renal-cell-carcinoma/2025-09-12T08:14:28+00:00weekly0.7https://www.medthority.com/guidelines/deficiency-and-other-anaemia/guidelines-for-the-management-of-iron-deficiency-anaemia/2025-09-29T13:27:26+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/guidelines-on-the-diagnosis-and-management-of-acute-pulmonary-embolism/2022-03-15T14:01:19+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-bone-and-connective-tissue/soft-tissue-and-visceral-sarcomas--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-08-12T13:19:21+00:00weekly0.7https://www.medthority.com/guidelines/macular-degeneration/age-related-macular-degeneration/2021-09-24T07:36:32+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/bsr-and-bhpr-guideline-on-prescribing-drugs-in-pregnancy-and-breastfeeding-part-i--standard-and-biologic-disease-modifying-anti-rheumatic-drugs-and-corticosteroids-/2023-05-31T13:10:45+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-disorders/2013-eta-guideline--management-of-subclinical-hypothyroidism/2023-05-30T09:58:05+00:00weekly0.7https://www.medthority.com/guidelines/hepatitis/easl-clinical-practice-guidelines-on-the-management-of-ascites--spontaneous-bacterial-peritonitis--and-hepatorenal-syndrome-in-cirrhosis-/2025-10-21T08:55:01+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/guidelines-for-the-diagnosis-and-management-of-cholangiocarcinoma/2025-09-12T08:13:24+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/eano-esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up-of-patients-with-leptomeningeal-metastasis-from-solid-tumours/2025-08-12T13:18:52+00:00weekly0.7https://www.medthority.com/guidelines/cardiac-arrest-and-ventricular-fibrillation/esc-guidelines-for-the-management-of-patients-with-ventricular-arrhythmias-and-the-prevention-of-sudden-cardiac-death/2025-09-15T12:54:04+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-uterus/endometrial-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-10-09T15:11:51+00:00weekly0.7https://www.medthority.com/guidelines/hepatitis/easl-clinical-practice-guidelines-for-the-management-of-patients-with-decompensated-cirrhosis/2025-10-20T14:23:44+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/bsh-guideline--management-of-thrombotic-and-haemostatic-issues-in-paediatric-malignancy/2025-02-18T14:59:39+00:00weekly0.7https://www.medthority.com/guidelines/osteoarthritis/eular-recommendations-for-the-use-of-imaging-in-the-clinical-management-of-peripheral-joint-osteoarthritis/2026-02-23T14:54:44+00:00weekly0.7https://www.medthority.com/guidelines/Testicular-Cancer/guidelines-on-testicular-cancer/2024-09-27T11:04:05+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/2016-update-of-the-asas-eular-management-recommendations-for-axial-spondyloarthritis/2023-05-31T12:43:19+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/atopic-eczema-in-under-12s-diagnosis-and-management/2025-06-16T08:42:17+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/eular-recommendations-for-the-use-of-imaging-in-the-diagnosis-and-management-of-spondyloarthritis-in-clinical-practice/2023-05-31T13:18:02+00:00weekly0.7https://www.medthority.com/guidelines/inflammatory-condition-of-skin/guidelines-on-the-measurement-of-ultraviolet-radiation-levels-in-ultraviolet-phototherapy--report-issued-by-the-british-association-of-dermatologists-and-british-photodermatology-group-2015/2025-11-10T14:54:15+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/early-and-locally-advanced-non-small-cell-lung-cancer--nsclc---esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-11-04T14:33:38+00:00weekly0.7https://www.medthority.com/guidelines/chronic-obstructive-pulmonary-disease-copd-and-bronchiectasis/gold-global-strategy-for-the-diagnosis--management-and-prevention-of-copd-/2025-09-22T08:15:49+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/guidelines-on-muscle-invasive-and-metastatic-bladder-cancer/2025-08-05T14:14:31+00:00weekly0.7https://www.medthority.com/guidelines/diabetes-mellitus-without-complication/management-of-hyperglycaemia-and-steroid--glucocorticoid--therapy/2025-10-09T10:59:34+00:00weekly0.7https://www.medthority.com/guidelines/mood-disorders/evidence-based-guidelines-for-treating-depressive-disorders-with-antidepressants--a-revision-of-the-2008-british-association-for-psychopharmacology-guidelines/2026-01-08T09:45:17+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-and-biological-disease-modifying-antirheumatic-drugs/2024-10-01T12:34:44+00:00weekly0.7https://www.medthority.com/guidelines/hepatitis/easl-clinical-practical-guidelines-on-the-management-of-acute--fulminant--liver-failure/2025-10-20T14:33:19+00:00weekly0.7https://www.medthority.com/guidelines/inflammatory-condition-of-skin/british-association-of-dermatologists-guidelines-for-biologic-therapy-for-psoriasis/2025-05-22T10:09:51+00:00weekly0.7https://www.medthority.com/guidelines/heart-valve-disorders/guidelines-on-the-management-of-valvular-heart-disease/2025-10-20T09:26:58+00:00weekly0.7https://www.medthority.com/guidelines/alcohol-related-disorders/children-and-young-people-exposed-prenatally-to-alcohol/2025-11-06T14:30:35+00:00weekly0.7https://www.medthority.com/guidelines/cushings-syndrome/treatment-of-cushing-s-syndrome--an-endocrine-society-clinical-practice-guideline/2025-11-10T11:05:16+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/guidelines-for-screening-and-management-of-late-and-long-term-consequences-of-myeloma-and-its-treatment/2026-01-08T10:13:43+00:00weekly0.7https://www.medthority.com/guidelines/substance-related-disorders/epa-guidance-on-tobacco-dependence-and-strategies-for-smoking-cessation-in-people-with-mental-illness/2021-12-28T14:59:03+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-rectum-and-anus/anal-cancer-esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-12T10:56:56+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/guidelines-for-the-diagnosis-and-management-of-acute-myeloid-leukaemia-in-pregnancy/2025-10-30T11:39:08+00:00weekly0.7https://www.medthority.com/guidelines/acute-renal-failure/acute-kidney-injury--prevention--detection-and-management-of-acute-kidney-injury-up-to-the-point-of-renal-replacement-therapy/2025-11-06T14:17:30+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/guidelines-on-the-investigation-and-management-of-follicular-lymphoma/2026-02-16T16:17:37+00:00weekly0.7https://www.medthority.com/guidelines/inflammatory-condition-of-skin/joint-american-academy-of-dermatology-national-psoriasis-foundation-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-with-phototherapy/2025-10-28T16:02:58+00:00weekly0.7https://www.medthority.com/guidelines/alzheimers-disease-and-dementia/clinical-practice-with-anti-dementia-drugs--a-revised--second--consensus-statement-from-the-british-association-for-psychopharmacology/2025-11-07T08:56:11+00:00weekly0.7https://www.medthority.com/guidelines/calculus-of-urinary-tract/guidelines-on-urolithiasis/2025-08-11T13:18:48+00:00weekly0.7https://www.medthority.com/guidelines/inflammatory-condition-of-skin/canadian-guidelines-for-the-management-of-plaque-psoriasis-2009/2025-11-10T14:49:53+00:00weekly0.7https://www.medthority.com/guidelines/venous-thromboembolism/british-thoracic-society-guideline-for-the-initial-outpatient-management-of-pulmonary-embolism/2023-06-02T14:04:01+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/national-clinical-guideline-for-stroke/2025-05-27T10:50:48+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/small-cell-lung-cancer--sclc---esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-11-04T14:41:52+00:00weekly0.7https://www.medthority.com/guidelines/retinal-disorders-and-injuries/retinal-vein-occlusion--rvo--guidelines/2023-06-01T08:11:44+00:00weekly0.7https://www.medthority.com/guidelines/inflammatory-diseases-of-female-pelvic-organs/guidelines-on-chronic-pelvic-pain/2025-10-30T10:09:33+00:00weekly0.7https://www.medthority.com/guidelines/prostate-cancer/eau-guidelines-on-prostate-cancer/2026-03-10T13:26:51+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/acute-lymphoblastic-leukaemia--esmo-clinical-practice-guidelines/2025-10-30T11:21:55+00:00weekly0.7https://www.medthority.com/guidelines/hepatitis/easl-clinical-practice-guidelines-on-hepatitis-e-virus-infection/2025-10-20T14:20:07+00:00weekly0.7https://www.medthority.com/guidelines/sexually-transmitted-infections/national-guideline-for-the-management-of-genital-molluscum-in-adults/2025-02-06T16:16:50+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-disorders/2018-european-thyroid-association--eta--guidelines-for-the-management-of-amiodarone-associated-thyroid-dysfunction/2023-07-25T13:51:50+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/biliary-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-12T08:12:59+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-rectum-and-anus/metastatic-colorectal-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-12T10:39:49+00:00weekly0.7https://www.medthority.com/guidelines/coagulation-and-haemorrhagic-disorders/guidelines-on-the-investigation-and-management-of-antiphospholipid-syndrome/2025-02-24T14:26:34+00:00weekly0.7https://www.medthority.com/guidelines/diabetes-mellitus-without-complication/the-hospital-management-of-hypoglycaemia-in-adults-with-diabetes-mellitus/2025-10-09T11:03:56+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/guidelines-for-diagnosis-and-management-of-hairy-cell-leukaemia-and-hairy-cell-leukaemia-variant/2025-10-31T09:25:03+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-disorders/2014-european-thyroid-association-guidelines-for-the-management-of-subclinical-hypothyroidism-in-pregnancy-and-in-children/2023-06-22T14:01:52+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/bsaci-guidelines-for-the-investigation-of-suspected-anaphylaxis-during-general-anaesthesia/2025-06-16T08:33:59+00:00weekly0.7https://www.medthority.com/guidelines/melanomas-of-skin/cutaneous-melanoma--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-11-24T14:55:53+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/bsaci-guidelines-for-the-management-of-egg-allergy/2025-06-16T08:31:48+00:00weekly0.7https://www.medthority.com/guidelines/adhd/evidence-based-guidelines-for-the-pharmacological-management-of-attention-deficit-hyperactivity-disorder--update-on-recommendations-from-the-british-association-for-psychopharmacology/2025-05-27T07:57:57+00:00weekly0.7https://www.medthority.com/guidelines/diabetes-mellitus-with-complications/the-management-of-diabetic-ketoacidosis-in-adults/2025-10-09T12:17:42+00:00weekly0.7https://www.medthority.com/guidelines/non-hodgkin-lymphoma/guidelines-on-the-diagnosis-and-management-of-waldenstrom-macroglobulinaemia/2026-02-16T16:10:27+00:00weekly0.7https://www.medthority.com/guidelines/cardiac-dysrhythmias/esc-guidelines-on-cardiac-pacing-and-cardiac-resynchronization-therapy/2025-09-15T13:08:49+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/bsr-and-bhpr-guideline-for-the-treatment-of-axial-spondyloarthritis--including-ankylosing-spondylitis--with-biologics/2023-05-31T13:00:18+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/bsr-and-bhpr-guideline-for-the-prescription-and-monitoring-of-non-biologic-disease-modifying-anti-rheumatic-drugs/2023-05-31T13:04:45+00:00weekly0.7https://www.medthority.com/guidelines/multiple-myeloma/multiple-myeloma--esmo-clinical-practice-guidelines/2026-01-08T10:03:53+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-disorders/2012-eta-guidelines--the-use-of-l-t4---l-t3-in-the-treatment-of-hypothyroidism/2023-05-30T09:59:20+00:00weekly0.7https://www.medthority.com/guidelines/other-diseases-of-bladder-and-urethra/guidelines-on-the-management-of-non-neurogenic-male-lower-urinary-tract-symptoms--luts-/2026-03-02T16:09:58+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/chronic-lymphocytic-leukaemia--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-10-31T08:38:40+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/bladder-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-08-07T12:33:09+00:00weekly0.7https://www.medthority.com/guidelines/urinary-tract-infections/guidelines-on-urological-infections/2023-05-24T10:18:11+00:00weekly0.7https://www.medthority.com/guidelines/gout/2016-updated-eular-evidence-based-recommendations-for-the-management-of-gout/2025-10-14T13:54:08+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/malignant-pleural-mesothelioma--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-11-04T14:25:07+00:00weekly0.7https://www.medthority.com/guidelines/breast-cancer/early-breast-cancer--esmo-clinical-practice-guidelines/2025-11-10T10:18:44+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/european-stroke-organisation--eso--guidelines-on-glycaemia-management-in-acute-stroke/2025-05-27T10:39:03+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/eular-evidence-based-and-consensus-based-recommendations-on-the-management-of-medium-to-high-dose-glucocorticoid-therapy-in-rheumatic-diseases/2023-05-31T13:49:13+00:00weekly0.7https://www.medthority.com/guidelines/sexually-transmitted-infections/united-kingdom-national-guideline-on-the-management-of-trichomonas-vaginalis/2023-05-30T13:40:22+00:00weekly0.7https://www.medthority.com/guidelines/mood-disorders/european-psychiatric-association-guidance-on-psychotherapy-in-chronic-depression-across-europe/2026-01-08T09:22:54+00:00weekly0.7https://www.medthority.com/guidelines/acute-cerebrovascular-disease/european-academy-of-neurology-and-european-stroke-organization-consensus-statement-and-practical-guidance-for-pre-hospital-management-of-stroke/2025-11-06T11:20:57+00:00weekly0.7https://www.medthority.com/guidelines/gastric-cancer/gastric-cancer--esmo-esso-estro-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-10-09T15:16:55+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/2013-european-thyroid-association-guidelines-for-cervical-ultrasound-scan-and-ultrasound-guided-techniques-in-the-postoperative-management-of-patients-with-thyroid-cancer/2025-05-20T10:24:44+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/guidelines-on-non-muscle-invasive-bladder-cancer--ta--t1-and-cis-/2025-08-05T14:24:52+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-brain-and-nervous-system/high-grade-glioma--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-11-10T10:29:30+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-other-male-genital-organs/guidelines-on-penile-cancer/2025-09-12T10:05:50+00:00weekly0.7https://www.medthority.com/guidelines/lung-cancer/thymic-epithelial-tumours--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-11-04T14:19:16+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-kidney-and-renal-pelvis/renal-cell-carcinoma--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-12T08:14:07+00:00weekly0.7https://www.medthority.com/guidelines/acute-coronary-syndrome/esc-eacts-guidelines-on-myocardial-revascularisation/2025-05-27T14:03:49+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-rectum-and-anus/rectal-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-12T10:48:09+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/acute-myeloblastic-leukaemias-in-adult-patients--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-10-31T08:58:04+00:00weekly0.7https://www.medthority.com/guidelines/glaucoma/glaucoma--diagnosis-and-management/2025-11-10T11:47:24+00:00weekly0.7https://www.medthority.com/guidelines/hodgkins-disease/guidelines-for-the-investigation-and-management-of-nodular-lymphocyte-predominant-hodgkin-lymphoma/2025-10-27T10:46:45+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/bsr-and-bhpr-guideline-on-prescribing-drugs-in-pregnancy-and-breastfeeding-part-ii--analgesics-and-other-drugs-used-in-rheumatology-practice/2023-05-31T13:13:13+00:00weekly0.7https://www.medthority.com/guidelines/hodgkins-disease/guidelines-for-the-first-line-management-of-classical-hodgkin-lymphoma/2025-10-27T10:57:27+00:00weekly0.7https://www.medthority.com/guidelines/bladder-cancer/guidelines-on-urothelial-carcinomas-of-the-upper-urinary-tract/2025-08-05T13:46:56+00:00weekly0.7https://www.medthority.com/guidelines/thyroid-cancer/thyroid-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-05-20T10:21:02+00:00weekly0.7https://www.medthority.com/guidelines/osteoporosis/management-of-osteoporosis-and-the-prevention-of-fragility-fractures/2026-02-24T14:54:49+00:00weekly0.7https://www.medthority.com/guidelines/headache/pharmacological-management-of-migraine/2025-10-16T12:42:16+00:00weekly0.7https://www.medthority.com/guidelines/cancer-of-liver-and-bile-duct/hepatocellular-carcinoma-esmo-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up/2025-09-12T08:13:13+00:00weekly0.7https://www.medthority.com/guidelines/leukaemia/hairy-cell-leukaemia--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-10-31T08:52:01+00:00weekly0.7https://www.medthority.com/guidelines/rheumatoid-arthritis/eular-recommendations-for-the-use-of-imaging-of-the-joints-in-the-clinical-management-of-rheumatoid-arthritis/2024-10-01T12:35:02+00:00weekly0.7https://www.medthority.com/guidelines/allergic-reactions/bsaci-guidelines-for-the-management-of-drug-allergy/2025-06-16T08:40:16+00:00weekly0.7https://www.medthority.com/guidelines/glomerulonephritis/kdigo-clinical-practice-guideline-for-glomerulonephritis/2025-10-14T10:17:48+00:00weekly0.7https://www.medthority.com/guidelines/inflammatory-condition-of-skin/clinical-practice-guideline-for-an-integrated-approach-to-comorbidity-in-patients-with-psoriasis-1/2025-10-28T15:50:20+00:00weekly0.7https://www.medthority.com/guidelines/fluid-and-electrolyte-disorders/intravenous-fluid-therapy-in-children-and-young-people-in-hospital/2025-10-09T14:42:10+00:00weekly0.7https://www.medthority.com/guidelines/ovarian-cancer/non-epithelial-ovarian-cancer--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2026-03-03T13:42:56+00:00weekly0.7https://www.medthority.com/guidelines/cancer-other-and-unspecified-primary/cancers-of-unknown-primary-site--esmo-clinical-practice-guidelines-for-diagnosis--treatment-and-follow-up/2025-09-15T10:22:11+00:00weekly0.7